ArticlePDF Available

Complementary therapies for stroke towards neurorecovery

Authors:

Abstract and Figures

Despite rapid advances in stroke management and rehabilitation therapy, no effective treatment is available for the later recovery phase following stroke. Therefore, complementary and alternative medicine system (CAM) has emerged as promising adjunct therapy for stroke management. CAM has its own cultural and philosophical aspects with different societies that drive as an inspiration and perception of less harmful and more effective strategies for stroke rehabilitation. However, robust scientific studies are required to establish CAM as an alternative therapy adjunct to conventional stroke treatment. A thorough literature search was performed using standard web databases such as PubMed, Google Scholar, ResearchGate, Scopus using ‘complementary and alternative medicine in stroke’ as the major keyword. Research and review articles containing latest preclinical and clinical studies were primarily included in this review. Moreover, different stroke treatment strategies mentioned in ancient scriptures were also considered. CAM therapy is parallelly practiced along with clinically approved stroke therapy worldwide. It has been also reported beneficial on post-stroke neurorehabilitation in different population-based studies. Currently, CAM suffers various limitations, including defined end-point, clear outcomes, the exact mechanism of action, and proper assessment of the patient’s physical and emotional needs. Nevertheless, CAM is being used to treat various diseases globally. However, their usage pattern differs according to a population's geography and socio-cultural background. The review briefly discusses different CAM used as stroke rehabilitation therapy and their promising role in adjunct stroke management strategies.
Content may be subject to copyright.
Vol.:(0123456789)
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Discover Medicine
Review
Complementary therapies forstroke towardsneurorecovery
AnirbanBarik1· ChetsiShah2· GautamKarmarkar1· JyotMotivaras1· TanishaMajumdar1,3· BijoyaniGhosh1·
NikitaRana1· AishikaDatta1· HeliShah4· SudhirShah5· PallabBhattacharya1
Received: 15 July 2024 / Accepted: 10 March 2025
© The Author(s) 2025 OPEN
Abstract
Background and purpose Despite rapid advances in stroke management and rehabilitation therapy, no eective treatment
is available for the later recovery phase following stroke. Therefore, complementary and alternative medicine system
(CAM) has emerged as promising adjunct therapy for stroke management. CAM has its own cultural and philosophical
aspects with dierent societies that drive as an inspiration and perception of less harmful and more eective strategies
for stroke rehabilitation. However, robust scientic studies are required to establish CAM as an alternative therapy adjunct
to conventional stroke treatment.
Methods A thorough literature search was performed using standard web databases such as PubMed, Google Scholar,
ResearchGate, Scopus using complementary and alternative medicine in stroke’ as the major keyword. Research and
review articles containing latest preclinical and clinical studies were primarily included in this review. Moreover, dierent
stroke treatment strategies mentioned in ancient scriptures were also considered.
Result CAM therapy is parallelly practiced along with clinically approved stroke therapy worldwide. It has been also
reported benecial on post-stroke neurorehabilitation in dierent population-based studies.
Conclusion Currently, CAM suers various limitations, including dened end-point, clear outcomes, the exact mechanism
of action, and proper assessment of the patient’s physical and emotional needs. Nevertheless, CAM is being used to treat
various diseases globally. However, their usage pattern diers according to a population’s geography and socio-cultural
background. The review briey discusses dierent CAM used as stroke rehabilitation therapy and their promising role in
adjunct stroke management strategies.
Keywords Complementary medicine· Alternative medicine· Stroke· Rehabilitation· Adjunctive therapy
1 Introduction
Stroke is the second leading cause of death worldwide, accounting for 6.55 million fatalities in 2019—or around 11.6%
of all deaths [13]. A stroke occurs when the brain’s blood flow gets reduced due to interruption [4]. It is caused due
to blocked or broken arteries supplying blood, oxygen, and nutrients to or within the brain. In 2019 the projected
number of incidents and prevalent strokes were 12.22million (70% increment from 1990) and 101.47million (85%
increment from 1990), respectively [1]. Stroke has been identified to be the third major contributor to disability
* Pallab Bhattacharya, pallab.bhu@gmail.com; pallab.bhattacharya@niperahm.res.in | 1Department ofPharmacology andToxicology,
National Institute ofPharmaceutical Education andResearch (NIPER), Ahmedabad,Gandhinagar382355, Gujarat, India. 2Department
ofNeurology, Sumandeep Hospital, Vadodara, Gujarat, India. 3Department ofBiotechnology, KIIT University, Bhubaneshwar, Odisha,
India. 4Sterling Hospital, Ahmedabad, Gujarat, India. 5Department ofNeurology, SVPIMSR, Director ofNeurosciences, Sterling Hospital,
Ahmedabad, Gujarat, India.
Vol:.(1234567890)
Review
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
globally, accounting for 143.23million disability-adjusted life years (DALYs) in 2019, which is 32% more than the year
1990 [1]. Although approximately 70% of stroke cases occur specifically in middle and low-income countries, India is
experiencing an astounding rise, with 1.8 million cases reported annually [5, 6]. According to a report, stroke is the
fifth leading contributor to DALYs in India [7]. This resulted in around 6.5 million prevalent stroke cases in 2016, 7.1%
of all deaths [8]. Although there are regional variations in the incidence of stroke, the Southern and Eastern regions
have the highest rates [9]. According to most of the studies, the incidence of stroke is more prevalent among men
than women in India [1014]. According to American Heart Association, ischemic, hemorrhagic, transient ischemic
attack (TIA), cryptogenic, and stroke affecting the brainstem are the latest subsets of stroke [15]. Stroke caused due
to arterial occlusion, i.e., ischemic stroke, accounts for 87% of all stroke cases. Transient ischemic attack, on the other
hand, is caused due to an impermanent blood clot, also termed a mini-stroke. Hemorrhagic stroke causes vascular
rupture, whereas cryptogenic stroke is one for which the etiology still cannot be identified [15]. Based on recent
studies, high blood pressure, ambient particulate matter pollution, body mass index, high fasting blood glucose,
and smoking are major risk factors that can trigger stroke [1, 3, 8]. Apart from these, high BMI emerged as another
critical stroke risk factor between 1990 and 2019 [1].
Camilo R. Gomez once stated, "Time is brain," referring to how quickly and permanently neurons in the brain are
destroyed according to time following a stroke. A typical patient may lose 1.9million neurons, 13.8billion synapses,
and 12km of axonal fibers per minute when a large vessel ischemic stroke remains untreated [16]. If therapy is unsuc-
cessful, the brain loses as many neurons each hour as it does in approximately 3.6years of average aging [16]. Indeed,
the more prolonged treatment is put off, the lower the likelihood it will be effective. Therefore, early intervention
significantly limits the damage to the penumbral neurons [1618].
It is well-known that stroke management is challenging and complex, with limited FDA-approved treatments such
as tissue plasminogen activators (tPAs) and mechanical thrombectomy (MT) [19]. Stroke impacts people’s health and
quality of life throughout the illness but necessitates significant healthcare resources, including medical expenditures
and long-term care costs [20]. As a result, complementary and alternative medicine gained popularity among stroke
patients and their families, predominantly in developing countries like India, Chile, and Africa [21]. Earlier reports
suggest that stroke patients will most likely observe considerable functional improvement during the first three to
six months of complementary and alternative medicine (CAM) treatment [22, 23]. Positive perception towards CAM,
mainly in Asians, may be attributed to the harmlessness of traditional medicine and their cultural connection with
society [2426]. Some key variables driving the usage of CAM treatment include the higher expense of conventional
therapy, illiteracy in rural regions, discontent with modern medicine, and the perception of elderly people [24, 26,
27]. Some barriers to CAM usage may include lack of scientific evidence, disbelief in the safety and efficacy, and
unhygienic practices by CAM practitioners [24, 27]. According to World Health Organisation (WHO), complementary
or alternative medicines are a broad group of healthcare methods not included in a country’s conventional practices
and may be used interchangeably with traditional medicine [28, 29].
The use of CAM varies significantly by geography since various cultures and traditions approach healthcare dif-
ferently (Fig.1). Several CAM treatments originated in Asia and are still actively practiced there. Traditional Chinese
medicine (TCM), Ayurveda, and acupuncture are all standard CAM therapies throughout Asia. Herbal therapy, cupping,
and tai chi are other CAM therapies popular in Asia [3033]. CAM is also popular in Europe. Homeopathy, osteopathy,
and naturopathy, acupuncture are a few of Europe’s most popular CAM techniques [34, 35]. In North America, CAM
utilization is more diverse, with various methods being implemented. Acupuncture, massage treatment, and chiro-
practic care are popular in the United States and Canada [3640]. In North America, herbal medicine, aromatherapy,
and meditation are popular [41, 42]. Traditional healing practices coexist with modern medicine in many regions
of Africa. Traditional healers use a variety of CAM therapies, such as herbal medication, bone setting, and spiritual
healing [43, 44]. Traditional healers are acknowledged by the government in certain countries, such as South Africa,
and are incorporated into the public healthcare system [45]. Traditional Mexican healing, along with herbal medicine,
massage treatment, and acupuncture, is widespread across Latin America [40, 4648]. It’s worth noting that CAM
procedures might differ considerably even within the same area or nation.
It was found that acupuncture, herbal therapy, cupping, and moxibustion are popular therapies in Asian countries,
particularly in East Asia [3133, 4951]. Whereas, in Southeast Asian nations such as Indonesia, Malaysia, and Thailand,
herbal medicine, massage, and energy healing therapies such as Reiki and Qi Gong are more popular [5254]. Traditional
Chinese medicine, Ayurveda, and Persian medicine impact the CAM therapies practiced in Central Asia. Massage, cupping,
and herbal therapy are some of the most common treatments in this area [31, 5557]. Ayurveda, which started in India
over 5000years ago, is South Asias leading traditional medicine practice [58, 59]. It is a holistic approach to healing that
Vol.:(0123456789)
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Review
balances the body and mind via herbal medication, food, meditation, and other lifestyle practices. Yoga, homeopathy,
naturopathy, acupuncture, chiropractic, Unani, and Siddha medicines are some of India’s most extensively utilized com-
plementary treatments, along with Ayurveda [6063]. Since March 1995, the Department AYUSH under the Ministry of
Health and Family Welfare has certied CAM practitioners in India [64].
In a study by Pandian JD etal., 314 stroke patients were interviewed, of which 230 (73.2%) were men. Among these
314 patients, 114 (36.3%) received the CAM treatment. Majority of subjects used were Ayurvedic massage, 67(59.3%)
followed by intravenous uids, 22(19.5%); herbal medicines, 17(15%); homeopathy, 15(13.3%); witchcraft, 3(2.7%); acu-
puncture, 3(2.7%); and other non-conventional treatment, 10(8.8%). Severe stroke (P < 0.0001), limb weakness (P < 0.0001),
dyslipidemia (P = 0.007), dysphagia (P = 0.02), hypertension (P = 0.03), and patients with poor outcome (P < 0.0001), all
predicted CAM usage. Among CAM users, 35.2% reported a considerable improvement, mostly in walking pattern (36.8%)
and lower limb (18.4%) and upper limb (15.8%) strength [64].
To strengthen traditional medicine’s role in public health, WHO launched the "WHO traditional medicine strategy
2014–2023" in 2013, with the goal of assisting member states in developing action plans and proactive policies to
strengthen the role of traditional medicine in public health[28]. This strategy is implemented to promote traditional
and complementary medicine use that is both safe and eective by appropriate regulation, research, and integration of
CAM practitioners, products, and practices in the health system [28].
Moreover, in March 2022, the Ministry of AYUSH (Government of India) signed an agreement with the WHO to set up
the WHO Global Centre for Traditional Medicine (GCTM) at Jamnagar, Gujrat. The center would be funded by a USD 250
million investment from the Indian government. The goal of this project is to strengthen the foundation of the public
health care system by utilizing the potential of complementary and alternative therapies through modern science and
technology [65]. The quality of life and speed of recovery of stroke survivors could be enhanced by ensuring that CAM is
used safely and eectively through regulation, research, and integration into the conventional health system. Patients
who choose CAM treatments often quit conventional medical care, so it’s essentialto keep in touch with the primary
care physician.
Fig. 1 Geographical distribution of dierent complementary and alternative medicines (CAM)- Asia has the highest varieties of CAM prac-
tices that include Traditional Chinese medicine (TCM), Ayurveda, acupuncture, herbal therapy, cupping, and tai chi. In the Europe, home-
opathy, osteopathy, naturopathy, and acupuncture are more in use. The North America reports maximum practice of acupuncture, massage
treatment, chiropractic care, herbal medicine, aromatherapy, and meditation. Traditional Mexican healing, herbal medicine, massage treat-
ment, and acupuncture are reported to be practiced more in South America. The Africa reports CAM practice using herbal medication, bone
setting, and spiritual healing
Vol:.(1234567890)
Review
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
2 Methods
A comprehensive literature search was conducted using standard online databases like PubMed, Google Scholar,
ResearchGate, and Scopus. We screened abstracts and titles of English-language studies using complementary therapy”,
“alternative medicine”, “traditional medicine” stroke”, and/or “adverse eects” as the primary keywords. This study mostly
comprised research and review publications with the most recent preclinical and clinical trials. Additionally, many stroke
treatment strategies that were referenced in ancient scriptures were taken into consideration.
3 Role ofAYUSH (Ayurveda, Yoga, Unani, Siddha, andHomeopathy) instroke management
3.1 Role ofAyurveda instroke management
Ayurveda is one of the ancient traditional medicine systems that believe the entire human physiological functions are
balanced by three basic senses of humor (dosha) [66]. These three humors are- Vata dosha, Pita dosha, and Kapha dosha,
collectively known as ‘Tridoshas.’ Vata is believed to control the catabolism of the body, whereas metabolism and anabo-
lism are governed by Pita and Kapha respectively [67]. It also considers neurological disorders are a result of Vata disorder
[67]. In Ayurveda, neurological treatment aims to maintain harmony between these Tridoshas (Fig.2). The treatment of
hemiplegia due to cerebral infarction includes therapies such as- snehan, swedana, virechana, and vasti, which involve
Ekangavir Rasa, Kaishore Guggulu, Sanjivani Vati, and Brihat Vatachintamoni Rasa as medication [68].
Hemiparesis (Pakshaghata) and its subdivisions are well classied in Ayurveda, along with their specic treatments
[68]. In the ‘Charak Samhita’ (Chikitsa sthana- chapter28), Acharya Charak has described hemiparesis as vata nanatmaj
vyadhi [67]. Whereas, in the Sushruta Samhita (Nidana sthana, chapter1), Acharya Sushrut has mentioned it as mahavat-
vyadhi [68]. Both the Acharyas recommended treatment protocols for hemiparesis that include- snehana, swedana,
Fig. 2 Pathophysiologi-
cal basis of dierent CAM
practices- Conventional
treatments of stroke are based
on cellular changes in ionic
gradient, excitotoxicity, and
changes in dierent intracel-
lular signaling pathways.
Whereas, Ayurveda believes in
imbalance between tridosha,
viz, vata, pitta and kapha can
result into post-stroke hemi-
plagia. On the other hand,
Unani believes on imbalances
between four humours of
body can result into stroke.
Chinese herbal medicine
believes on the alteration of
ve basic elements can result
in stroke and post-stroke
outcomes in a human body.
To maintain these balance
within the body, Aromather-
apy, music supported therapy,
acupuncture, moxibustion,
hirudotherapy and cupping
are practiced
Vol.:(0123456789)
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Review
mridu virechana, basti karma, and murdhani. Chapter28 of Chikitsa sthana in Charak Samhita, hemiparesis is classied
as ‘paksha-vadha’, ‘ekanga-roga’ and ‘sarvanga roga’ [67]. According to Charak Samhita, paralysis of any one side of the
body by aggravated vayu causes immobility of that side and results in enormous pain and loss of speech, which is termed
‘paksha-vadha’ [67]. When the aggravated vayu aicts half of the body and may constrict vessels and ligaments, resulting
in contracture in one leg or hand with piercing pain, that is termed as ‘Ekanga-roga’. Finally, if any of these pervade the
entire body, it is termed as ‘Sarvanga-roga’ [67].
The eective line of treatment has been mentioned as ‘oleation therapy’ that includes the consumption of ghee, muscle
fat, oil, and bone marrow in the initiation of the treatment [67]. After a gap of few times, the treatment can be continued
with the help of milk, vegetable soup, and meat soup of domesticated/ aquatic/ small marshy-land inherited animals.
Following proper oleation, fomentation therapy should be started that includes ‘nadi-sveda’, ‘prastara-sveda, ‘sankara-
sveda’ etc. The basis of these therapies believes that curved and sti limbs can be slowly brought back to their own
normal structure by oleation and fomentation therapies [67]. The softened body will immediately alleviate the tingling
sensation, pricking pain, ache, contracture and edema [67]. The oleation therapy is believed to provide instantaneous
nourishment to emaciate tissue elements and promotes strength to the Agni (enzymes of metabolism), plumpness and
elan vitae. Although inappropriate preparation of these formulation may lead to some adverse eects (Table1). The thera-
pies should be given repeatedly so that the viscera (kostha) remain soft and the tridoshas remain in harmony. However,
if inappropriate administration of the therapies happens, patient should undergo elimination therapy with the help of
mild drugs that includes medicated ghee prepared by boiling either with ‘tilvaka’ or ‘satala. The therapy also includes
the consumption of castor oil with milk, which helps in rapid elimination of morbid materials for health benets. If the
patient is unsuitable for elimination or purgation therapy, a ‘niruha’ type enema can be prepared with ‘pacana (carmina-
tive) and dipana (stimulant of digestion). In addition, patients with vayu disorders should be continuously given a diet
containing sweet, sour, saline, and unctuous, along with inhalation and smoking therapies [67].
Sushruta Samhita says that when aggravated vayu invades down, side, and upward ligaments or nerves (dhamanis),
it results in loosening of joints, destroying one half of the body, or commonly described as ‘pakshaghata’ [68]. If half of
the body gets destroyed (i.e. inactive) by vata/vayu alone, then it is dicult to cure [68]. However, if it is associated with
other doshas it is curable. In Chikitsa sthana, chapter4, Sushruta described therapies such as sneha (oleation), sveda
(sudation), abhyanga (oil bath and massage), basti (enema), sneha virechana (oily purgatives), sirobasti (enema to the
head), sirohsneha (oiling the head), snaihika dhuma (lubricating smoke inhalation), sneha gandusa (lubricating mouth
gargles), and snehika nasya (lubricating oily nasal drops) all should be comfortably warm [68]. In chapter15, nidanasthana
of Ashtanga Hridaya described hemiparesis as an imbalance of tridoshas similar to Charak Samhita. It says, when vata/
vayu seizes half of the body, it is called ‘ekangaroga’. Likewise, when whole body is invaded by vata, it is called ‘sarvanga-
roga’. In chapter21, chikitsa sthana, it is described as vata dosha alone can be treated by ghee, muscle fat, marrow or oil
consumption. Weak patients should be ensured by consuming milk, soup, meat, milk pudding, rice boiled with grams,
etc. by anuvasana (oil enema), navana (nasal medication), tarpana food with fats along with sudation therapy by sankara
sveda. However, even with these therapies the diseases do not subside, then sodhana or purication therapies should
be done with mild drugs mixed with milk [68].
A pilot study on a branch of Ayurveda similar to acupressure therapy named ‘adjunct marma’ therapy, reported a
benecial eect of massage therapy [69]. The response rate of the study was 91%; however, no signicant dierences
in the ecacies were noticed in the scores. The follow-up score as a secondary measure showed dierences of the
Motricity Index at 6 and 12weeks. The trunk control test at 6weeks reports improvement in the intervention group
(p < 0.05, p < 0.01) [69]. A randomized clinical trial (RCT) that compared 2 dierent Ayurvedic muscle-nourishing process
Navarakizhi and pinda sweda were applied in chronic stroke patients with hemiplegia [70]. In the study, 18 patients with
hemiplegia for 6months to 2years received treatment for 7days. Both groups received the same Ayurvedic oral medica-
tions for 14days. The intraquartile range showed better response in patients who received navarakizhi than those who
received pinda sweda [70].
Another study on Ayurveda-induced improvement in cardiac autonomic dysfunction following stroke as an adjunc-
tive treatment received standard allopathic medications as per neurologists [71]. In addition, randomized patients were
divided to two groups. First, to receive physiotherapy (Group I) and second, to receive Ayurveda treatment (Group II) for
14days. Patients in Group II reported statistically signicant improvement in dierent cardiac autonomic parameters.
There were signicant enhancements in the standard deviation of normal to normal intervals, and total and low frequency
powers (F = 8.16, P = 0.007, F = 9.73, P = 0.004, F = 13.51, and P = 0.001, respectively). The baroreex sensitivity increased
following the treatment period (F = 10.129, P = 0.004) [71]. It is the rst study that reported adjuvant Ayurveda treatment
in ischemic stroke can positively modulate cardiac autonomic activity [71].
Vol:.(1234567890)
Review
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Table 1 Reported adverse events related to dierent CAM practices
Sl. no Therapy Expected adverse eect(s) References
1 Ayurveda Presence of heavy metals and alkaloids, can have adverse events like jaundice, abdominal discomfort, hepatic failure when prepared
inappropriately [183, 184]
2 Yoga Soreness and pain, muscle injuries and fatigue [185]
3 Unani Certain Unani formulations like Habb-e-Shifa that is used as anti-pyretic anti spasmodic agent, has found to cause dilation of pupil
leading to visual impairment and photophobia in patients [186]
4 Homeopathy Allergic reactions, atopic dermatitis, leucocytosis, gastrointestinal illness, hair loss, and cardiac, renal, pulmonary and hematological
adverse events [187, 188]
5 Tai Chi Increased risk of joint injury, falls and overexercise leads to musculoskeletal strain [189, 190]
6 Acupuncture Infection, blood vessel injury and bleeding, tissue and nerve damage, irritation around thestimulation site [191, 192]
7 Chinese Herbal Medicine (CHM) Presence of toxic ingredients and contaminants like heavy metals, dierent western drugs may cause cardiovascular, neurological,
gastrointestinal, hematological, and renal adverse events [193, 194]
8 Massage therapy Minor nerve injuries, bruises, and blood clot dislodgment [195]
9 Aromatherapy Allergic reactions, headache, respiratory issues, drug interactions, CNS overstimulation. [196]
10 Chiropractor Therapy Vertebral artery dissection, neck pain, and slipped disc [197]
11 Moxibustion Increased heat leads to skin irritation, burns andskin cracks leading to infection and inammation [50]
12 Hirudotherapy Hemorrhagic shock, anemia, pain and occasional infection [198]
13 Cupping Skin irritation, bruising, burns, headache, muscle tension and soreness [199, 200]
14 Reiki Muscle tightness, pain and pressure sensations [201]
Vol.:(0123456789)
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Review
Another observational study prospectively compared outcomes in 2 cohorts of acute ischemic stroke (AIS) patients.
One treated with whole-system classical Ayurveda (n = 13) and another with conservative (nonthrombolytic, nonin-
terventional) Western biomedicine (n = 20). The outcomes were statistically non-signicant in mortality rates (15.38%
vs 15%, P = 1.00), nonfatal adverse event rates (15.38% vs 30%, P = 0.4), and functional disability measures. It is the rst
ever stand-alone report describing similar safety proles of classical Ayurveda and conservative Western biomedicine
following AIS [72].
3.2 Role ofYoga inStroke Management
According to Ministry of Ayush, Government of India, ‘Yoga’ means ‘to unite’. It implies the union of individual spirit with
the universal spirit of almighty. It is a combination of practices to engage with the world to create harmony [73]. As a
discipline, Yoga means- to engage, to participate, to get involved, and to connect [73]. Yoga involves several mind and
body practices that claim to use interactions among the mind, body, and behavior to promote optimal health over the
lifespan and improve dierent aspects of physical and mental health [74]. Modern Yoga has eight components: Yama or
moral disciplines, Niyama or positive observances, Asanas or postures, Pranayama or regulated breathing, Pratyahara or
sense withdrawal, Dharana or focussed concentration, Dhyana or meditation, and Samadhi or enlightenment [75]. Despite
of some reported adverse events (Table1), there are many positive correlations of Yoga have been reported that can be
considered stroke preventive measures. A meta-analysis of 6 trials demonstrated that yoga was associated with a reduc-
tion in systolic and diastolic blood pressure (− 5mmHg and − 4mmHg) respectively [76]. It is also reported to be eective
in smoking cessation, downregulating inammatory markers, and reducing stress and anxiety [7780]. A study by Schimd
etal., reported benecial eects of yoga in male stroke survivors in a Veteran Hospital (NCT01109602- Registration dates:
First Submitted- 2010-04-02, First Submitted that Met QC Criteria- 2010-04-21, First Posted (Estimated)- 2010-04-23). The
patients were categorized into three groups viz, Group Yoga, Yoga plus i.e., group yoga with home training and control
patients. Following yoga training, the patients reported improvement in balance, quality of life, reduced fear of falling,
improvement in doing daily life activity independently [81].
3.3 Role ofUnani inStroke Management
Unani medicine (“Unani-Tibb”) is one of the old systems of healing, which originated in ancient Greece (Unan) and has its
presence in various civilizations such as the Arab, Rome, and Spain [82]. Buqrā (Hippocrates, 460 BCE) introduced this
traditional Perso-Arabic system of medicine, while other scholars such as Galen, Ibn Betar, and Zakarya Razes inuenced
the advancement of the same [83]. Between the thirteenth and seventeenth centuries, Arabic physicians integrated it
with Indian medicinal plants, which helped it to spread throughout the Indian subcontinent [84]. It is based on the prin-
ciple of equilibrium of the proximal kaiyat (qualities) of which the body is made: the four arkān (elements), four akhlā
(humours), and four mizāj (temperaments) of the human body [82]. The four elements (earth, air, water, and re) along
with the four humours, which are blood (dum), phlegm (balgham), yellow bile/ bilious (afrā), and black bile/ melancholic
(saudā) controls the four temperaments (cold, dry, wet, and hot) (Fig.2) [82, 83]. The dierent temperaments are based
on the humour of the person while the umoor-e-tibiiya (forces of nature) and three arwah (forces) controls the simple
and compound a’dā’ (organs) of the body [82, 84]. Evaluation of the imbalance of the humours is done through nabz
(pulse), urine, and stool tests [83]. Following tashkhees (diagnosis), the treatment may be in the form of ilajbid-dawa
(pharmacotherapy), ilajbit-tadbeer (regimental therapy/lifestyle modication), ilajbil-ghiza (diet therapy), and jarahat [83].
The entire Unani treatment for stroke is based on the principle of Ta’deel (equalizing the temperament of the aected
organ) and Tanqiya (elimination of the main cause) [85, 86]. Regaining the humoral balance by the use of single or poly-
herbal remedies along with dietary control has been explored as eective management for stroke treatment (Fig.3) [87].
Preventive measures using pharmacotherapy which either includes either mufrad advia (single crude drugs) derived from
natural sources or murakkab advia (compound drugs) have been recorded in Unani treatment for stroke [88]. In unani
medicine garlic, (Allium sativum) Linn. is known as Seer in Persian and Saum in Arabic [89]. In the book Al Qanoon-l-Tib
(The Canon of Medicine) garlic has been recommended as antihyperlipidemic and antihypertensive [89]. The attributes
of this crude drug are to reduce the risk of ischemic stroke by reducing blood pressure and cholesterol levels. Garlic has
been reported as eective for post-stroke rehabilitation in the regimental approach of Unani medicine [84]. Post-stroke
hemiplegia (Fālij-i-Nisf) according to unani literature denotes istirkha (paralysis) of the longitudinal half of the body along
with loss of motor functions also with or without sensory functions [85]. The dalk (massage) therapy using the Unani
pharmacopoeial formulation of garlic oil (Roghan Seer) was documented to have signicant improvement in lower limb
Vol:.(1234567890)
Review
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
mobility in post-stroke hemiplegic patients [90]. Other formulations such as Roghan Qustand other medicated oils were
reported to improve the Fugl-Meyer upper limb score for hemiplegia caused by stroke and other musculoskeletal and
nervous system disorders [84]. In a rat model of permanent middle cerebral artery occlusion of stroke, Ginkgo biloba
extract has been reported as a potential therapeutic drug for the improvement of motor function [91]. The same has
been a part of the Unani formulations because of its pharmacological activity as an antagonist for platelet-activating
factor and it also increases cerebral blood ow, thus making this herb an integral part of the CAM for geriatric patients
[92]. Similarly, Ginger (Zingiber ocinale Roscoe) is another well-known CAM for stroke, whose fresh rhizome is known
as Saunth and Zanjabeel. In unani literature, it is recorded as an eective herb for platelet aggregation, improving
circulation, and reducing the fructose-induced elevation of lipid levels [93, 94]. The combination of these single drugs
has been formulated into compound drugs in the Unani system. Majun Khadar is such a Unani herbal formulation that
has shown protection against hippocampal neurochemical alterations and behavioral dysfunctions in rat model of
transient focal cerebral ischemia [87]. It is a preparation of 27 constituents, which has anti-inammatory, vasodilation,
nerve stimulant, and free radical scavenging (antioxidative) activities. Thus, this formulation exerts a synergistic eect
of these constituents on oxidative stress and inammatory condition in ischemic neuronal death. Other Unani herbal
compound formulations such as Khamira Abresham and Majun Baladar also have similar neuroprotective ecacy in
focal cerebral ischemia [95, 96].
The Unani treatment for stroke is based on the technique of ripening and expellingthe humoral substance with a
honey-based formulation (ma-ul-asal) and extract of eight to ten herbs. This technique is reported to treat the weakness
in the patient within 45–90days completely [83], although these claims aren’t supported with substantial proof. Various
clinical trials have been conducted using poly-herbal unani formulations to improve post-stroke conditions in patients.
Unani literature states that hemiplegia is mainly caused by the obstruction to the passage of nerve impulses (rūh-inafsāni)
[82]. Stroke is treated by the comprehensive package of Ta’deel (massage of the paralyzed limbs) and Tanqiya (poly-herbal
formulations) in Unani medication. In a single-arm clinical trial of 30 clinically diagnosed post-stroke hemiplegic patients,
the oral administration of Unani formulation of phlegmatic concoctive drugs (Joshanda Munzij-i-Balgham) for 15days
followed by dry cupping (Hijamah Bila Shart) of paralyzed limbs for 10min daily (16th to 30th day), reported improved
Fig. 3 A comparative
representation of conven-
tional stroke treatment with
dierent CAM practices- Con-
ventional stroke treatment is
based on reperfusion theory,
i.e., earliest removal of occlu-
sion to achieve neuropro-
tection. Whereas, various
CAM practices rely on their
traditional belief. Ayurveda
believes on the treatment
method that includes olea-
tion (Snehan), perspiration
(Swedan), metabolism (vire-
chan), and enema application
(vasti). It also relies upon Yoga,
that is helpful in post-stroke
rehabilitation. Homeopathy
believes in serial dilution
method that is directly
proportional to the potency
of the medication. Unani
applies dierent combination
of medications containing
common natural ingredients.
Chinese herbal medicine
has dierent classications
that deal with various other
treatment methods including
Tai-chi, massage therapy, aro-
matherapy, acupuncture, etc.
Vol.:(0123456789)
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Review
motor recovery [82]. A similar result was reported by another single-blind, randomized, and standard-controlled clini-
cal trial of 40 patients and open observational clinical trial of 30 patients, based on both pre- and post-stroke Stroke
Rehabilitation Assessment of Movement (STREAM) criteria. In this study, the combination of oral poly-herbal decoction
(Nuskha munzije balgham, Nuskha Mushile Balgham, and Munzije Balgham) for Tanqiya and Ta’deel with massage of the
spinal column and paralyzed limbs with Roghan Malkangani [86, 97]. Through these clinical trials, the limitations of this
contemporary treatment were evaluated based on scientic parameters, which hinted towards a promising potential of
this therapy for the treatment of stroke.
3.4 Role ofHomeopathy inStroke Management
Homeopathic medicine or homeopathy (Greek: omeos” meaning similar and “pathos” meaning suering) was founded
by Samuel Hahnemann, a German physician in 1796 [98, 99]. Dr. John Martin Honigberger an Imperial Austrian physician
introduced it to India in 1839 [100]. This two-century-old system of healing is mainly based on the principle of similars,
similia similibus curentur, in simple words “like cures like”, which is very similar to the concept of immunization (used in
allopathic medicine)[98, 101]. This rst postulate of homeopathy states that if a substance causes symptoms of illness in
a healthy person, then that same substance can cure similar symptoms in another patient [99]. The preparation is done
by serial dilutions with strong strokes for potentization [101]. The second postulate, the principle of dilutions is contro-
versial since it states that higher dilution of a substance increases its potential [99]. This potentiation of biological action
is generally attended by dilution above Avogadro’s number [99]. The principle of the minimum dose is based on the
previous principle, where the undesirable eects are minimized by serial dilutions (called “potencies”) of the medicine.
This helps to determine the minimum dose that is optimal for treating the disease [102, 103]. The last postulate is of a
single remedy, in which one medicine that is tested (provings), should be able to overcome all the symptoms (physical,
emotional, and mental) of the illness [103]. The sources of homeopathic medicines are generally based on herbal, animal,
and their by-products, along with other mineral and energy origins[101]. Generally, homeopathic drugs are marketed
by their scientic names and diluted in a certain solvent for potentiation (Fig.3).
In preclinical models of stroke in rats, it has been reported that certain homeopathic drugs such as Arnica Montana
and Crotalus horridus improved the outcome of cerebral ischemia [104]. The drugs were tested in two dierent poten-
cies, 200C and 30C, pre- and post-stroke for 5days respectively [104]. Thus, the study stated that these medications may
have a potential prophylactic neuroprotective role. In an open-label pilot study the eectiveness of homeopathy for fty
stroke patients was explored as an adjuvant therapy to standard conventional care [105]. Out of the total fty patients
included, ten had suered from a stroke episode more than 1year ago and were suering from sequelae, while the
other twenty-seven patients had their episode between one month to one year and the thirteen patients had a recent
episode within 4weeks. The medications used were Causticum, Arnica Montana, Nux vomica, Lycopodium, and Lachesis,
while the assessment was done based on the National Institute of Health Stroke Scale (NIHSS) Score after six months
of treatment. Statistical seventy-six percent of the patients had a better recovery while none of the patients had any
worsening symptoms or manifestation of new infarcts [105]. In spite of few general adverse eects (Table1), the pres-
ence of positive reviews towards homeopathic medicines in both clinical and preclinical studies of stroke presents it as
a potential member of the CAM for the treatment of stroke.
4 Other complementary therapies
4.1 Tai Chi (TC)
Tai Chi Chuan is a mind–body relaxation exercise, consisting 108 forms taking 30min to perform altogether [106].
Studies reported that tai chi improves independent activities of daily living, especially when compared between with
conventional rehabilitation therapy [107]. Tai chi also increases the Fugl-Meyer Assessment score for the upper limb,
lower limb and overall score following stroke. The Berg Balance Scale revealed signicant improvements according to a
pooled estimation study of tai chi vs. conventional rehabilitation therapy [107].
In China, TC is extensively used for functional recovery following stroke [108]. TC possesses various dierent styles, such as
Sun, Yang and Chen. It has been reported to modulate neural function and biomechanics of balance by improving neuromus-
cular responses and increasing balance by various strategies. Studies reported that in TC trained individual, post-stroke bilat-
eral dorsolateral prefrontal cortex and hippocampus shows increased functional connectivity and low frequency uctuations
Vol:.(1234567890)
Review
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
in amplitude [108]. Although with some reported shortcomings (Table1), TC practitioners showed benecial eect on the
white matter of brain that are directly linked to the duration of TC practice and skills [109]. Post-stroke TC practice has also
been reported to attenuate anxiety and depression [110].
4.2 Acupuncture
In acupuncture method, metallic needles are inserted at specic locations in the body which are termed accupoints. Fol-
lowing insertion, manipulation of the needle is performed using heat or electric current. Acupuncture therapy with electric
current between two acupoints through needles is nowadays being used by various trained acupuncture therapists [111]. In
traditional Chinese medicine, acupuncture plays an important role. Studies reported that acupuncture improves neurologi-
cal decits of stroke patients [112]. Acupuncture is also reported to be benecial in acute pain [113]. Evidences show that
acupuncture activates adenosine triphosphate (ATP) and transient receptor potential vanilloid (TRPV) channels at acupoint
area. Analgesia by acupuncture is found due modulation neurotransmissions including serotonin, norepinephrine, opioids,
endocannabinoid and orexin in central nervous system (CNS) [113]. Out of several post-stroke disabilities, hemiplegia is one
of the common disabilities seen across patients, which occurs in the form of muscle weakness of the aected side along with
limb spasm. Acupuncture is found to be eective in rehabilitation therapy for post-stroke for improving the severe eects
of hemiplegia [4]. Evidences from clinical trial shows benecial eect of acupuncture in post-stroke balance impairment,
muscular spasticity and muscle strength [114]. Neurogenesis and cell proliferation are also possible by acupuncture in the
central nervous system. Increased cerebral blood ow and anti-apoptotic eect resulting into improved post-stroke awed
long-term potentiation (LTP) and memory are reported following acupuncture therapy [114]. Cellular proliferation is reported
in infarct region and some contiguous zones to the injury in a middle cerebral artery occlusion model, where neurogenesis
was hiked in subventricular zone of the lateral ventricle and the dentate gyrus of the hippocampus following acupuncture
[115]. Acupuncture is also reported to enhance stem cell proliferation following up-regulation of GSK-3β/PP2A expression,
neurotrophic factors (brain-derived neurotrophic factor or BDNF and vascular endothelial growth factor or VEGF) and retinoic
acid expression [115, 116]. It is crucial to maintain a proper practicing skill and setup/environment for this, since there are
reports of various adverse conditions such as infection and nerve damage (Table1). Electro-acupuncture (EA) has reported
to increase numbers of neuroblasts in the hippocampus and subventricular zone [116].
Some acupoints are majorly used for post-stroke treatment, which are Shuigou, Dazhui, Baihui, Zusanli, Hegu and
Quchi. On which acupuncture exerts its eect through various mechanisms [114]. Following cerebral ischemia, EA treat-
ment activates the Wnt/β-catenin pathway enhancing proliferation of neural progenitor cells [117]. EA can also upregulate
mRNA expression of stem cell factors and matrix metallopeptidase-9 (MMP-9) [118]. EA can activate ERK1/2 pathways
and cyclin expression [119, 120] and neuroprotection can be obtained by proliferation of glial brillary acidic protein
(GFAP)/vimentin/nestin-positive phenotypic astrocytes by enhancing BDNF expression in the peri-infarct cortex and
striatum [121].
EA at Hegu upregulates the expression of VEGF and angiogenin-1 that simultaneously inhibit endostatin which
downregulates angiogenesis [122]. At Dazhui, Shuigou and Baihui increases release of acetylcholine by which nitric
oxide is released that increases reperfusion on the ischemic portion [123]. Acupuncture is reported eective in stroke
rehabilitation and motor dysfunction based on assessments of neurological impairment, global neurological decit,
ADL functionality or water-swallowing ability [124]. Study shows that cognitive function is beneted signicantly and
depression along with anxiety are attenuated by Interactive Dynamic Scalp Acupuncture (IDSA) which increases self-
care ability of patient [125].
5 Chinese herbal medicine (CHM)
Chinese herbal medicinesin ischemic stroke were reported benecial in neurological decit on stroke scales. The improve-
ment has been measured in neurological decit score via dierent parameters such as Canadian Neurological Scale,
European Stroke Scale or Modied Edinburgh-Scandinavian Stroke Scale [110]. Studies shows that use of CHM as adjunc-
tive therapy in type 2 diabetes with stoke can increase overall survival rate [126].
Various CHM(s) are found to be benecial in post-stroke that includes Ginkgo biloba, Gastrodia elata, Rehmannia gluti-
nosa, Panax notoginseng. Dierent active ingredients extracted from CHMs are well studied for treatment of post-stroke
disabilities which has multiple mechanism of actions [127]. Some important CHM and their mechanism of actions are
as follows-
Vol.:(0123456789)
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Review
Tanshinone IIA (TA) – TA is derived from dried roots and rhizomes ofSalvia miltiorrhiza called Danshen which is used
in China to treat cerebrovascular diseases [128]. Studies show that TA inhibits glial cell activation, reduces apoptosis,
and decreases oxidative stress. TA sulfonate attenuates MCAo-induced upregulation of autophagy-associated proteins
(Beclin-1, Sirt 6 and LC3-II) and exerts neuroprotection [129].
Baicalin (BA)—It is isolated from dried roots of Scutellaria baicalensis which is widely used CHM [130]. BA is a natural
avonoid and possesses anti-inammatory, antioxidant and anti-apoptotic ecacies. BA has the ability to penetrate blood
brain barrier and decreases activity of MMP-9 by downregulating its expression. BA reverses the haemorrhagic trans-
formation of ischemic stroke after treatment of tPA and decreases mortality rate signicantly. Studies show the ecacy
of BA in improving the learning and memory decits in global cerebral ischemia by diminishing the phosphorylation of
CaMKII that leads to hippocampal neuronal apoptosis prevention [131134].
dl-3-n-butylphthalide (DLNBP)—It was earlier extracted from the seeds ofApium graveolensLinn. as l-3-n-butylphthal-
ide. Afterwards it was synthesized in lab as a racemic mixture dl-3-n-butylphthalide and it became the rst drug with
independent intellectual property rights for use in cerebrovascular disease treatment in China [135]. DLNBP increases
neurogenesis, axonal growth, ATP metabolism and enhances remyelination. It elevates expression of VGLUT1 and PSD95
and of sonic hedgehog expression [136139].
Gastrodin (gas)—Gas is isolated from G. elataBlume, which is called tianma in Chinese [140]. Gas reduces ischemic
injury post-stroke by inhibiting apoptosis and it also inhibits Zinc (Zn+2)induced toxicity leading to death of cells, Gas is
found to be anti-inammatory and anti-oxidant improving oxidative damage, it promotes neurogenesis and angiogenesis
leading to its use as a promising rehabilitation therapy post-stroke [141144].
Ginsenoside (GNS)—It is a saponin compound isolated from P. notoginseng and P. ginsengC, which have multiple actions
for treatment of stroke [145]. Studies found that they exert an angiogenic eect via activation of VEGF modulating the
PI3K/AKT/mTOR pathway. They also exert anti-inammatory activity and reduce serum levels of TNF-α, IL-1ß and IL-6. They
can also show anti-coagulant, anti-oxidant and anti-apoptotic activities. Studies reported that GNS can downregulate
protease-activated receptor (PAR-1) [146150] and shows benecial role in neurological disorders.
Tetramethylpyrazine (TMP)—It is an alkaloid extracted from the rhizome of the Chinese herbRhizoma Chuanxionga
[151]. Evidences show that TMP decreases the infarct volume post stroke, modies behavioral functions and neurologi-
cal functions, improves neurogenesis and oligodendrogenesis and decreases blood brain barrier permeability. TMP is
reported to be benecial by decreasing free radicals, maintaining the mitochondrial Ca+2 overload, increasing the plas-
ticity of dendrites and decreasing the expression of MMP-9 and AQP4 [152154].
5.1 Massage therapy
One of the earliest methods of rehabilitation, massage therapies work on the principle of mechanotransduction. Valdes
etal., in their systematic review, highlighted the wide practice of massage therapies in Asia for stroke rehabilitative
approaches [155]. A tenet of rehabilitation, mechanotransduction, is a process by which a cell converts mechanical
inputs into biochemical signals. In a study conducted to assess the eect of massage therapy on cellular functions post-
exercise-induced muscle damage, the researchers found that massage therapy results in clinical benets by reducing
inammation and promoting mitochondrial biogenesis [156]. Massage promotes muscular compliance and reduces
stiness by raising blood ow and temperature in the muscle mass, although few cases of minor nerve injuries, bruises
are reported (Table1) [157]. Several kinds of therapeutic massage have been reported, such as Swedish massage, Chinese
massage (Tuina), Indian massage (Dalk), and Thai massage. Research has found positive eects of therapeutic massage
on motor function, spasticity, behavioral symptoms, pain, stroke disability, and quality of life of stroke survivors. In a
meta-analysis of ndings of therapeutic massage for improving sequelae in stroke survivors, it was found that Tuina
massage is the most widely used form of massage used in treating stroke-related symptoms [155]. Tuina massage as an
adjunct to physiotherapy and electric acupuncture has been found to be eective in treating shoulder-hand pain [155,
158, 159]. When combined with Unani exercises, it was found that tuina massage improves upper limb functions, speed
of walking and the gait of stroke patients with unilateral hemiplegia or paralysis [155]. Esther Mok and Chin Pang Woo
(2004) in their study found that ten minutes of slow-stroke back massage (SSBM) for 7days signicantly reduced the pain
perception and anxiety of elderly stroke patients [160]. It is also reported that traditional tuina combined with current
rehabilitation therapy can successfully reduce or eliminate upper limb spasticity and improve daily living clinically [161].
Vol:.(1234567890)
Review
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
5.2 Aromatherapy
Aromatherapy is the application of essential oils as an additional form of treatment for a variety of physical and mental
illnesses [162]. Essential oils can be administered orally, topically, inhaled, intraperitoneally, or subcutaneously, following
which their individual elements can all pass through the blood–brain barrier and enter the central nervous system [163].
Its extensive usage as a therapeutic approach has been reported in several diseases of the nervous system—depres-
sion, migraine, chronic pain in multiple sclerosis and behavioral disturbances in dementia. Aromatherapy combined
with acupressure has been reported to be eective in reducing hemiplegic shoulder pain and improvement of motor
function post-stroke clinically [164].
A study evaluating the neuroprotective eects of Curcuma oil in a rat embolic stroke model found that a single-dose
intraperitoneal administration of the oil 30min before a stroke can reduce brain neutrophil inltration, expression of nitric
oxide synthase and neurodegeneration [165]. Vakili etal. found that lavender oil treatment (doses of 200 and 400mg/kg)
considerably improved functional outcomes following cerebral ischemia by reducing infarct size and brain edema [166].
For instance, 200mg/kg of lavender oil reduced the amount of malondialdehyde (MDA) while simultaneously increasing
the activities of glutathione peroxidase, superoxide dismutase, and total antioxidant capacity [166].
Treatment with curcumin has also been found to greatly enhance neurological functions and aid in reducing brain
damage by attenuating Blood–brain Barrier disruption [167]. Amantea etal. (2009) have demonstrated the neuroprotec-
tive mechanisms of intraperitoneal administration of bergamot essential oil (BEO) [168]. BEO can prevent excitatory amino
acid export and ROS generation, which can revert the functioning of glutamate transporters in ischemia situations [168].
Though only preliminary work has been conducted to assess the eect of aromatherapy in humans, its benets have
been reported for pain-related symptoms, behavioral symptoms (stress, quality of sleep, delirium) as well as clinical
symptoms (motor and language) [169]. A study conducted by Shin and Lee (2007) evaluated the benets of aromatherapy
with essential oils of lavender, rosemary and peppermint diluted in jojoba oil, as an additive therapeutic approach to
acupressure, in stroke patients with hemiplegic shoulder pain (HSP) where they found a signicant reduction in HSP fol-
lowing acupressure-aromatherapy with respect to acupressure is the only therapeutic approach [164]. Lee etal. (2017)
in their study, evaluated the eect of aromatherapy massage which included a combination of juniper, lavender, orange,
patchouli, and rosemary, on behavioral symptoms [170]. These researchers noted signicant reductions in body tempera-
ture along with improvements in psychological stress, mood status, and sleep quality [170]. Despite consistent positive
ndings of aromatherapy in stroke rehabilitation in human studies, it has been linked to occasional adverse events, such
as allergic reactions, respiratory issues in some other medical conditions (Table1). So, further research work needs to be
conducted to standardize the appropriate dosage or procedure of this therapeutic approach. The eect of aromatherapy
reaches beyond the pain domain and exerts positive eects on behavioral symptoms as well and has the potential to be
used in conjunction with other therapies to treat motor, behavioral and emotional problems in stroke patients.
5.3 Chiropractor therapy
Chiropractic therapy involves treating the subluxated spinal segments using a variety of manual procedures, including
high-velocity, low-amplitude adjustments which are often referred to as spinal manipulation. The main focus of this
therapeutic approach is the relationship between the spinal cord and the nervous system [171]. In this method, vertebral
subluxations are identied using pathophysiological indicators of spinal dysfunction and corrected with the help of sev-
eral manual techniques [172]. Emerging evidence has brought to light the eect of chiropractic care on somatosensory
processing, sensory integration, and motor control following just a single session [173].
Single-session chiropractic benets- A research study aimed at investigating the eects of a single session of chiropractic
care in stroke patients found that following at least one chiropractic adjustment to their cervical, thoracic and lumbopel-
vic spinal regions, plantarexion muscle strength rose by 64.2% on average [173]. The same study also attempted to
investigate the underlying mechanisms that modulate the potential changes in strength and found that the observed
changes in strength were more heavily inuenced by an increased cortical drive than spinal excitability [173]. A rand-
omized cross-over study of 17 male stroke patients found that a single chiropractic spinal adjustment session raised the
amplitude of the N30 somatosensory evoked potential (SEP) peak indicating changes in early sensorimotor integration
[174]. However, the functionalsignicance or longevity of any of these changes is not known yet.
Long-term chiropractic sessions- A randomized controlled trial involving 63 stroke patients investigated the eects
of longer-term chiropractic care on motor functions of the participants [175]. The study found that the combination
Vol.:(0123456789)
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Review
of chiropractic spinal adjustments and physical therapy signicantlyimproved lower limb motor functions of stroke
patients though these eects were no longer persistent at the 8-week follow-up. Chiropractic has also been found to
bring about an improvement in the health-related quality of life of stroke survivors though further investigation would
help determine the robustness of this application.
Chiropractic care may be crucial for a range of clinical groups if it improves spinal functions and has a central neuronal
plastic inuence since it is thought that brain plasticity holds the key to encouraging motor-function recovery in stroke
patients.
5.4 Moxibustion
Moxibustion is the practice of applying heat to certain body parts—skin and subdermal tissues called acupoints by
burning moxa (mugwort), shaped in the form of a cone, placed on those acupoints. [176]. Current research reports
moxibustion to be benecial as an adjunct to standard approaches for stroke rehabilitation, on motor function [177]. The
usage of dierent types of moxibustion techniques such as, suspended moxibustion, warm-needle moxibustion, and
indirect moxibustion have been reported in the treatment of stroke-related symptoms [178]. Research has found that
warm needle moxibustion helps in alleviating muscle spasticity by accelerating metabolism, dilating blood vessels, and
decreasing nerve excitability [179]. Few studies reported adverse events like allergy, infection, burns associated with the
moxibustion in dierent medical condition (Table1). A novel device called “plum blossom needle with mild moxibus-
tion is currently undergoing clinical trials for assessing its feasibility in widespread clinical practice for upper limb pain
disorder and motor symptoms of post-stroke patients with shoulder-hand syndrome (PS-SHS) [180]. It has been found
that moxibustion, when used as an adjunct therapy for PH-SHS, exerts favorable eects on the improvement of regional
skin congestion, activation of blood and lymphcirculation, capillary expansion, sedation, and analgesic nature [180].
A systematic review and meta-analysis of RCTs conducted to assess the eect of moxibustion on cognition and activi-
ties of daily living (ADL) post-stroke found that it signicantly enhanced cognitive function and ADL in stroke patients,
who received moxibustion treatment as compared to the control group [181]. Another review conducted to assess the
ecacy of moxibustion for the treatment of post-stroke depression (PSD) found that current literature supports the pos-
sibility of moxibustion as an eective intervention for PSD [182]. However, the reliability of the ndings from randomized
clinical trial on moxibustion therapyis limited and the extent of eectiveness of this therapy is yet to be explored.
5.5 Music‑supported therapy (MST)
Music-supported therapy(MST) involves providing appropriate stimulation to improve physical, cognitive, and emotional
impairments resulting from stroke [202]. Using real-time auditory feedback, MST has been used to improve the upper limb
motor function [203]. Music-supported therapy (MST) is one of the most frequently used treatment for hand function
related problems. A growing body of literature has highlighted the benets of MST in treating stroke-related symptoms
[202, 204]. The observed benets can be attributed to the combination of auditory sensory input along with movement
training. Besides, this sensory stimulation brought on by music can induce functional recovery in injured hemispheres.
Studies reported that a 4-week MST program, can improve hand mobility, uency, and speed of work in stroke patients. In
order to train both ne and gross motor abilities, music-supported therapy utilizes playing a keyboard and/or electronic
drum utilizing motor sequences of escalating diculty [204]. Clinical research has found 30min of active playing over
a period of 4weeks in addition to conventional is benecial in improving paretic upper body movement parameters,
such as speed, precision and smoothness [202]. Though consistent positive ndings exist on MST in stroke rehabilita-
tion, recent intervention protocols have suggested an increase in intensity and duration may be required to promote
eective motor recovery for chronic stroke patients [202]. Current research has indicated that music-based intervention
has great potential for supporting or recovering motor function and could be a powerful tool in stroke rehabilitation.
5.6 Hirudotherapy
Hirudotherapy, is the use of medicinal leeches for therapeutic purposes, and has been used in traditional medicine from
centuries to treat various ailments, including stroke [205]. Hirudo medicinalis is one of the best species used in hirudother-
apy. The leeches are believed to contain hundreds of bioactive compounds that have anticoagulant, anti-inammatory,
and analgesic properties, which can help improve blood ow and reduce swelling in the aected area [206, 207].
Vol:.(1234567890)
Review
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Leech saliva contains nerve growth factor, which is known to promote the growth and survival of neurons and promote
neuroplasticity [208]. Although there is limited research performed to establish the exact mechanisms by which hirudo-
therapy promotes neural plasticity. However, some studies suggest that hirudotherapy may help to stimulate the growth
of new neurons and synapses, and promote the rewiring of neural circuits in the brain [209]. One potential mechanism by
which hirudotherapy may promote neural plasticity is through the secretion of growth factors by the medicinal leeches.
Hirudotherapy may also promote neural plasticity by increasing blood ow to the aected area. Improved blood ow
can help to provide oxygen and nutrients to the brain, which can support the growth and survival of new neurons and
synapses [210]. The results suggested that hirudotherapy may promote neural plasticity by improving the recruitment of
neurons in the aected area and promoting the growth of new neurons. Furthermore, hirudotherapy may promote neu-
ral plasticity by reducing inammation and oxidative stress in the brain. Inammation and oxidative stress can damage
brain tissue and hinder the growth of new neurons and synapses, so reducing these factors can help to promote neural
plasticity and recovery [211]. Nonetheless, leech saliva contains hirudin which is one of the most potent anti- coagulants;
that supress the process of blood clotting. Apart from this leech saliva contains many other substances having in anti-
inammatory, analgesic, vasodilation, and bacteriostatic action. All this action contributes to the elimination of damaged
vascular tissues, elimination of hypoxia, reduction of blood pressure and increase in immunity [212, 213].
5.7 Cupping
Cupping therapy is the physical treatment reported about 1550 BC by Ebers papyrus, it is one of the part oldest healing
system and used in many ailments [214]. Initially cupping was classied into two types by Hippocrates i.e., dry, and wet,
but later in 2013 it was developed and categorised into 5 types later in 2016 it was updated and further categorised into
6 types [215, 216]. Although cupping categorized into many types dry and wet cupping are most famous. Dry cupping
is the non-invasive method where skin is pulled in the cups by suction, without drawing the blood and in wet cupping
skin is pulled in the cups where stagnant ow of blood is maintained. The cups used for cupping are made with dierent
materials such as glass, bamboo, or plastics [217220].
Cupping therapy is being used for myriad of diseases from ancient times, and it was the most frequently used remedy
in modern east Asian traditional medicine till date [221]. There are several literatures have been reported about cupping
therapy but evidence of using for stroke is lacking behind. However wet cupping have shown the favourable eect for
stroke rehabilitation in 2 RCT [222]. 3 RCTs and 2 systematic reviews have reported that cupping is ineective therapy
for stroke. However, Huang etal. studied the eect of pricking and cupping on the abdominal center for biceps after
stroke and showed that combined therapy of pricking and cupping along with conventional stroke rehabilitation could
contribute signicantly to the improvement in hand function and reducing spasticity in stroke patients [223]. However,
a meta-analysis done by Kim etal., compared wet cupping with the active control drug baclofen for controlling muscle
tone in dierent post-stroke patients reported that the patients receiving wet cupping therapy oers signicantly more
improvement in muscle tone than patients with baclofen [221]. There are other studies in which cupping has shown
superior eect as compared to acupuncture in hemiplegic shoulder pain and upper limb myodynia after stroke [222].
The possible mechanism of cupping to improve the outcome is due to letting out excess of uid and toxins from blood,
bringing blood to the stagnant skin and muscles or giving negative pressure to promote stroke rehabilitation [219, 224].
There are limited scientic studies have been done so far although cupping therapy is using from ancient times in stroke.
Due of lack of clear evidences on cupping therapy, it is controversial to use in stroke as an alternative therapy. However
well designed and more robust scientic studies are needed to establish the cupping therapy for stroke [224].
5.8 Reiki
Reiki is the Buddhist healing therapy which was originated thousands of years ago in Tibetan Sutras and then re-estab-
lished by Buddhist monk in mid-nineteenth century in Japan. The word reiki is composed of two Japanese words one is
‘rei’ that means supreme being, and other is ‘ki’ that means universal life energy [225]. Reiki is a spiritual practice where
practitioner believes that the energy is transferred from healer to the patient and promote self-healing, maintains har-
mony and balance to the body and mind. The practitioner who performs the reiki therapy should have at least three years
of practice. The goal of reiki therapy is to direct the way of healing energy from practitioner to the patient [226]. It is used
in number of ailments and diseases including cancer, edema, dyspnoea, pain, stress, and anxiety [227] [228]. However
the use of reiki in stroke is lacking; One study done on patients with subacute stroke undergoing standard rehabilitation
therapy for 3weeks and reported that reiki is not signicantly eective in those patients [229]. In systematic review they
Vol.:(0123456789)
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Review
analysed 12 studies relevant to the reiki as CAM therapy for stroke patients but nally reported about 31 outcome stat-
ing that the reiki therapy is still on the exploratory mode [226]. Although there are very few studies has been conducted
so far, they are poor in quality, suggesting that to establish the reiki therapy as CAM for stroke more robust and quality
scientic studies are needed.
6 Conclusion andfuture prospects
Post-stroke impairment depends on the severity of brain injury and accessibility of initial interventions. Various pre-
clinical and clinical studies have reported benecial eects of CAM in dierent neurological disorders as well as in stroke.
CAM along with conventional stroke management strategies may improve post-stroke rehabilitation. Owing to reported
adverse events (Table1), proper treatment regime of CAM may further be explored. A robust pre-clinical and clinical
studies are necessitated to decipher the molecular mechanisms required for establishing CAM as one of the rehabilita-
tion therapies for stroke.
Acknowledgements Department of Pharmaceuticals, Ministry of Chemical and Fertilizers, Govt. of India and National Institute of Pharma-
ceutical Education and Research (NIPER) Ahmedabad, Gandhinagar, India. Authors acknowledge www. biore nder. c om for image preparation.
Author contributions Bibliographic analysis: AB, CS, GK, JM, TM, BG, NR, AD, HS, SS and PB.; writing original draft preparation: AB, GK, JM, TM,
BG, NR, AD, and PB and; intellectual inputs and editing by all authors; Proof reading: CS, HS, SS and PB.; All authors have read and agreed to
the nal version of the manuscript.
Data availability Not applicable.
Declarations
Ethics approval and consent to participate Not applicable.
Patient consent Not applicable.
Competing interests The authors declare no competing interest.
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which
permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to
the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modied the licensed material. You
do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party
material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If
material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds
the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creat iveco
mmons. org/ licen ses/ by- nc- nd/4. 0/.
References
1. Feigin VL, etal. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden
of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820.
2. Saini V, Guada L, Yavagal DR. Global epidemiology of stroke and access to acute ischemic stroke interventions. Neurology. 2021;97(20
Suppl 2):S6-s16.
3. Rennert, R.C., etal., Epidemiology, Natural History, and Clinical Presentation of Large Vessel Ischemic Stroke. Neurosurgery, 2019. 85(suppl_1):
p. S4-s8.
4. Guo, X. and B. Cheng, Clinical Eects of Acupuncture for Stroke Patients Recovery. Journal of Healthcare Engineering, 2022. 2022.
5. Global, regional, and national age-sex-specic mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic
analysis for the Global Burden of Disease Study 2017. Lancet, 2018. 392(10159): p. 1736–1788.
6. Network , T.N., Only 1 in 4 Indians aware about brain attack, says national survey, in The Times of India. 2022, Times News Network: Mumbai.
7. Askew K, et al. Coupled proliferation and apoptosis maintain the rapid turnover of microglia in the adult brain. Cell Rep.
2017;18(2):391–405.
8. The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016.
Lancet Glob Health, 2018. 6(12): p. e1339-e1351.
Vol:.(1234567890)
Review
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
9. Kodali NK, Bhat LD. Prevalence and associated factors of stroke among older adults in india: analysis of the longitudinal aging study in
india-wave 1, 2017–2018. Indian J Public Health. 2022;66(2):128–35.
10. Dhamija R, etal. Emerging Trends in Stroke Epidemiology in Indian Women Over the Last Decade. Neurol India. 2022;70(1):315–8.
11. Kamalakannan S, etal. Incidence & prevalence of stroke in India: a systematic review. Indian J Med Res. 2017;146(2):175–85.
12. Dhamija RK, Dhamija SB. Prevalence of stroke in rural community–an overview of Indian experience. J Assoc Physicians India.
1998;46(4):351–4.
13. Navghare, P.S., K.S.M. , and M.B. , Study of clinical prole, risk factors & CT scan nding among patients with cerebrovascular accident at a
tertiary care hospital. European Journal of Molecular & Clinical Medicine, 2023. 10(02): p. 1789–1795.
14. Kumaresan DR Evaluation of the risk factors and clinical features of stroke in correlation with ct scan ndings in (general medicine). 2007,
the tamilnadu dr. M.G.R. Medical Univeristy Chennai, India. p. 114.
15. Association, A.S. Types of Stroke and Treatment. About Stroke [cited 2023 MArch 16]; https:// www. stroke. org/ en/ about- stroke/
types- of- stroke.
16. Saver JL. Time is brain–quantied. Stroke. 2006;37(1):263–6.
17. Gomez CR. Editorial: time is brain! J Stroke Cerebrovasc Dis. 1993;3(1):1–2.
18. Gomez CR. Time is brain: The stroke theory of relativity. J Stroke Cerebrovasc Dis. 2018;27(8):2214–27.
19. Ghosh D, etal. Drug repurposing for stroke intervention. Drug Discovery Today. 2022;27(7):1974–82.
20. Prince MJ, etal. The burden of disease in older people and implications for health policy and practice. Lancet. 2015;385(9967):549–62.
21. Payyappallimana, U. Role of traditional medicine in primary health care: an overview of perspectives and challenging. 2010.
22. Mf A, etal. Prospective study of functional recovery of stroke patients at three months post admission: outcomes and implications for
post stroke care provision. Med Health. 2013;8:19–27.
23. Kwakkel G, Kollen B, Lindeman E. Understanding the pattern of functional recovery after stroke: facts and theories. Restor Neurol Neu-
rosci. 2004;22(3–5):281–99.
24. Tangkiatkumjai M, Boardman H, Walker D-M. Potential factors that inuence usage of complementary and alternative medicine world-
wide: a systematic review. BMC Complementary Med Therapies. 2020;20(1):363.
25. Truant TL, etal. Complementary and alternative medicine (CAM) use in advanced cancer: a systematic review. J Support Oncol.
2013;11(3):105–13.
26. Bishop FL, etal. Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies. Prostate Cancer
Prostatic Dis. 2011;14(1):1–13.
27. James PB, etal. Traditional, complementary and alternative medicine use in Sub-Saharan Africa: a systematic review. BMJ Glob Health.
2018;3(5): e000895.
28. Organization, W.H. WHO traditional medicine strategy: 2014–2023. 2013 [cited 2023 13.03.2023]; https:// www. who. int/ publi catio ns/i/
item/ 97892 41506 096.
29. World Health, O., WHO global report on traditional and complementary medicine 2019. 2019, Geneva: World Health Organization
30. Complementary and Alternative Medicine for Menopausal Symptoms. A review of randomized, controlled trials. Ann Intern Med.
2002;137(10):805–13.
31. Fung FY, Linn YC. Developing traditional chinese medicine in the era of evidence-based medicine: current evidences and challenges.
Evidence-Based Complementary Alternative Med. 2015;2015: 425037.
32. Lim MK, etal. Complementary and alternative medicine use in multiracial Singapore. Complement Ther Med. 2005;13(1):16–24.
33. Lilly E, Kundu RV. Dermatoses secondary to Asian cultural practices. Int J Dermatol. 2012;51(4):372–82.
34. Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ. 2000;78(2):252–7.
35. Fisher P, Ward A. Complementary medicine in Europe. BMJ. 1994;309(6947):107–11.
36. Spigelblatt L, etal. The use of alternative medicine by children. Pediatrics. 1994;94(6 Pt 1):811–4.
37. Breuner CC. Complementary medicine in pediatrics: a review of acupuncture, homeopathy, massage, and chiropractic therapies. Curr
Probl Pediatr Adolesc Health Care. 2002;32(10):353–84.
38. McFarland B, etal. Complementary and alternative medicine use in canada and the united states. Am J Public Health. 2002;92(10):1616–8.
39. Ijaz N, Boon H. Evaluating the international standards gap for the use of acupuncture needles by physiotherapists and chiropractors: a
policy analysis. PLoS ONE. 2019;14(12): e0226601.
40. Najm W, etal. Use of complementary and alternative medicine among the ethnic elderly. Altern Ther Health Med. 2002;9:50–7.
41. Leach MJ. Prole of the complementary and alternative medicine workforce across Australia, New Zealand, Canada, United States and
United Kingdom. Complement Ther Med. 2013;21(4):364–78.
42. Wardle J, Lui C-W, Adams J. Complementary and alternative medicine in rural communities: current research and future directions. J
Rural Health. 2012;28(1):101–12.
43. Ezekwesili-Oli Josephine, O. and C. Okaka Antoinette Nwamaka, Herbal Medicines in African Traditional Medicine, in Herbal Medicine, F.B.
Philip, Editor. 2019, IntechOpen: Rijeka. p. Ch. 10.
44. Okpoko P, etal. Indigenous medical knowledge and bone setting among the igbo of Southeast Nigeria. J Educ Soc Behav Sci. 2018;26:1–9.
45. Omololu AB, Ogunlade SO, Gopaldasani VK. The practice of traditional bonesetting: training algorithm. Clin Orthop Relat Res.
2008;466(10):2392–8.
46. Kennedy L, Gonzales E, Corbin L. The eect of curanderismo on chronic non-malignant pain: a case report. EXPLORE. 2016;12(4):263–7.
47. Jernewall N, etal. Complementary and alternative medicine and adherence to care among HIV-positive Latino gay and bisexual men.
AIDS Care. 2005;17(5):601–9.
48. Sorrell TR. Mexican traditional medicine: application of a traditional and complementary medicine system to improve opioid use treat-
ment in latinos. J Holist Nurs. 2020;38(4):384–99.
49. Kim J-I, etal. Moxibustion for hypertension: a systematic review. BMC Cardiovasc Disord. 2010;10(1):33.
50. Park J-E, etal. Adverse events of moxibustion: a systematic review. Complement Ther Med. 2010;18(5):215–23.
51. Kim T-H, Kim D-H, Lee SG. Moxibustion therapy in traditional mongolian medicine. Chin J Integr Med. 2018;24(9):707–12.
Vol.:(0123456789)
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Review
52. Lockhart, J.S., M.G. Oberleitner, and D.A. Nol, The Asian Immigrant Cancer Survivor Experience in the United States: A Scoping Review
of the Literature. Cancer Nursing, 2020. 43(3).
53. Cassileth BR, etal. Alternative medicine use worldwide. Cancer. 2001;91(7):1390–3.
54. Joy, M., Role of Information Technology In Energy Healing Techniques -A Meta Analysis. 2021: p. 63–69.
55. Singh DAK. Inuence of buddhism in the development of contemporary healing traditions. World J Pharmaceut Res. 2018;7(6):391–9.
56. Ge, S., etal., A unique understanding of traditional medicine of pomegranate, Punica granatum L. and its current research status. J
Ethnopharmacol 2021. 271: 113877.
57. Singh YD, Panda MK, Satapathy KB. Ethnomedicine for Drug Discovery. In: Patra JK, Shukla AC, Das G, editors. Advances in Pharmaceutical
Biotechnology: Recent Progress and Future Applications. Singapore: Springer Singapore; 2020. p. 15–28.
58. Choudhary S, Chaudhary G, Kaurav H. Medicinal importance of Ephedra gerardiana in ayurveda and modern sciences: a review. Asian
J Pharmacy Pharmacol. 2021;7:110–7.
59. Saini R, Sharma S, Saini S. Ayurveda and herbs in dental health. Ayu. 2011;32(2):285–6.
60. Bordoloi J, etal. Ethnomedicinal Plants of North-East India as a Potential Target for Drug Discovery Against Type 2 Diabetes Mellitus. In:
Patra JK, Shukla AC, Das G, editors., etal., Advances in Pharmaceutical Biotechnology: Recent Progress and Future Applications. Singa-
pore: Springer Singapore; 2020. p. 39–54.
61. Sreenivasan TM. Role of alternate medicines in total health care. Anc Sci Life. 1985;4(4):191–6.
62. Panneerselvam NK, Ravindran D, Kathiresan A (2020) Morbidity prole of patients seeking Naturopathy and Yoga treatment in South
India: A descriptive study. J Complementary Integrative Med. 17(3).
63. Payyappallimana U (2010) Role of traditional medicine in primary health care : an overview of perspectives and challenges. 14: 57–77
64. Pandian JD, etal. Complementary and alternative medicine treatments among stroke patients in India. Top Stroke Rehabil.
2012;19(5):384–94.
65. Organizaion WH. WHO establishes the Global Centre for Traditional Medicine in India, in Maximizing potential of traditional medicines
through modern science and technology. Geneva: World Health Organizaion; 2022.
66. Harini JA, etal. Ayurvedic treatment of acute ischemic stroke: a prospective observational study. Global Adv Health Med.
2019;8:2164956119849396.
67. Jt, A., Charaka Samhita with Ayurveda Dipika commentary of Chakrapani Datta. Varanasi (India): Chaukambha Orientalia, 2007. 69.
68. Acharya JT (2010) SushrutaSamhita with Nibandhasangraha commentary by Dalhanacharya, Reprint edition. Varanasi: Chouk hambha
Sanskrit Sansthan 435.
69. Fox M, etal. Marma therapy for stroke rehabilitation–a pilot study. J Rehabil Med. 2006;38(4):268–71.
70. Guruprasad Aggithaya M, etal. Navarakizhi and pinda sweda as muscle-nourishing Ayurveda procedures in hemiplegia: double-blind
randomized comparative pilot clinical trial. J Altern Complement Med. 2014;20(1):57–64.
71. Jaideep SS, etal. Modulation of Cardiac Autonomic Dysfunction in Ischemic Stroke following Ayurveda (Indian System of Medicine)
Treatment. Evid Based Complement Alternat Med. 2014;2014: 634695.
72. Harini JA, et al. Ayurvedic treatment of acute ischemic stroke: a prospective observational study. Glob Adv Health Med.
2019;8:2164956119849396.
73. Ministry of Ayush, G.o.I. Denition of Yoga. 2021; https:// main. ayush. gov. in/ ayush- syste ms/ yoga/ den ition- of- yoga/.
74. Gothe NP, etal. Yoga eects on brain health: a systematic review of the current literature. Brain Plasticity. 2019;5(1):105–22.
75. Newlyn E The 8 Limbs of Yoga explained. 2023; https:// www. ekhar tyoga. com/ artic les/ philo sophy/ the-8- limbs- of- yoga- expla ined.
76. Sharma R, etal. Eects of yoga on blood pressure among prehypertensive and hypertensive individuals: a systematic review. Int J Yoga.
2019;12:S27.
77. Dai C-L, Sharma M. Between inhale and exhale: Yoga as an intervention in smoking cessation. J Evid-Based Complement Alternative
Med. 2014;19(2):144–9.
78. Bock BC, etal. Yoga as a complementary treatment for smoking cessation: rationale, study design and participant characteristics of the
Quitting-in-Balance study. BMC Complement Altern Med. 2010;10:1–8.
79. Estevao C. The role of yoga in inammatory markers. Brain Behav Immunity-Health. 2022;20: 100421.
80. Woodyard C. Exploring the therapeutic eects of yoga and its ability to increase quality of life. Int J Yoga. 2011;4(2):49.
81. Schmid AA, etal. Poststroke balance improves with yoga: a pilot study. Stroke. 2012;43(9):2402–7.
82. Ali M, etal. Ecacy of a poly-herbal Unani formulation and dry cupping in treatment of post-stroke hemiplegia: an exploratory, single
arm clinical trial. Adv Integrative Med. 2021;8(4):298–304.
83. Syeda A, Rughooputh S, Greenwell P. The Unani system of medicine: does it have a scientic basis? Biomed Sci. 2004;48(9):971–2.
84. Poulakou-Rebelakou E, Karamanou M, George A. The impact of ancient Greek medicine in India: the birth of Unani medicine. Acta
Medico-historica Adriatica: AMHA. 2015;13(2):323–8.
85. Nayab M, Kouser HV, Ansari AN. Tanqiya wa tadeel (evacuation and rejuvenation): the unani concept as evolutionary basis for conven-
tional stroke management. J Drug Delivery Therapeutics. 2021;11(1):195–200.
86. Yasir M etal. Evaluation of Ecacy of Unani Regimen in the Management of post Stroke Spasticity, an open observational Study. Age
(years), 2013. 53: 11.26.
87. Yousuf S etal. Neuroprotection oered by Majun Khadar, a traditional unani medicine, during cerebral ischemic damage in rats. Evid-
Based Complement Alternative Med, 2011. 2011.
88. Yasmeen A, So G, Khan K. Aamar-e-Advia (shelf-lives) of drugs in Unani system of medicine: a conceptual review. J Integrative Med.
2020;18(2):114–24.
89. Nasir A etal. Pharmacological and therapeutic attributes of garlic (Allium sativum Linn.) with special reference to Unani medicine—a
review. J Med Plants Stud 2020. 8(3): 6–9.
90. Haji A etal. Ecacy of massage with roghan seer in motor recovery in hemiplegia secondary to ischaemic stroke. 2011.
91. Zeng G-R, etal. Eect of Ginkgo biloba extract-761 on motor functions in permanent middle cerebral artery occlusion rats. Phytomedi-
cine. 2018;48:94–103.
Vol:.(1234567890)
Review
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
92. Cohen RJ, Ek K, Pan CX. Complementary and alternative medicine (CAM) use by older adults: a comparison of self-report and physician
chart documentation. J Gerontol A Biol Sci Med Sci. 2002;57(4):M223–7.
93. Ansari FR, Chodhary KA, Ahad M. A review on ginger (Zingiber ocinale Rosc) with unani perspective and modern pharmacology. J
Med Plants. 2021;9(3):101–4.
94. Wang Z (2022) Ginger extract compounds in treatment of ischemic stroke: Mechanisms and applications. in AIP Conference Proceedings.
AIP Publishing LLC.
95. Yousuf S, etal. Selenium plays a modulatory role against cerebral ischemia-induced neuronal damage in rat hippocampus. Brain Res.
2007;1147:218–25.
96. Yousuf S, etal. Protective eect of Khamira Abresham Uood Mastagiwala against free radical induced damage in focal cerebral ischemia.
J Ethnopharmacol. 2005;99(2):179–84.
97. Ahmed A, etal. Ecacy of Munzij wa Mushil-e-Balgham (poly herbal formulations) and massage with Roghan-e -Malkangani in Falij Nis
(Hemiplegia): a randomised controlled clinical trial. Int J Pharm Sci Res. 2015;6(1):453.
98. Sheikh A, etal. Nanoformulation of Calcarea Carb and Ocimum sanctum. Alternat Integrat Med. 2022;11(9):1–4.
99. Merrell WC, Shalts E. Homeopathy. Med Clin. 2002;86(1):47–62.
100. Durai Pandian J, etal. Complementary and alternative medicine treatments among stroke patients in India. Top Stroke Rehabil.
2012;19(5):384–94.
101. Schmidt JM. Similia similibus curentur: theory, history, and status of the constitutive principle of homeopathy. Homeopathy.
2021;110(03):212–21.
102. Castro M. Homeopathy: A theoretical framework and clinical application. J Nurse Midwifery. 1999;44(3):280–90.
103. Chopra, P. and P. Chopra, Homeopathy in dentistry-An overview. International Journal of Contemporary Dentistry, 2011. 2(2).
104. Khuwaja G, etal. Protective role of homoeopathic medicines on cerebral ischaemia in animals. Indian Journal of Research in Homoe-
opathy. 2014;8(4):209–17.
105. Abbas, A., etal., An open-label pilot study to identify the usefulness of adjuvant homoeopathic medicines in the treatment of cerebral stroke
patients. 2018.
106. Koh TC. Tai chi chuan. Am J Chin Med. 1981;9(01):15–22.
107. Lyu D, etal. Tai Chi for stroke rehabilitation: a systematic review and meta-analysis of randomized controlled trials. Front Physiol.
2018;9:983.
108. Hu, C., etal., Eects of tai chi exercise on balance function in stroke patients: an overview of systematic review. Neural Plasticity, 2022. 2022.
109. Yao J, etal. The eect of Tai Chi practice on brain white matter structure: a diusion tensor magnetic resonance imaging study. Res Sports
Med. 2019;27(1):121–30.
110. Venketasubramanian N. Complementary and alternative interventions for stroke recovery–a narrative overview of the published evi-
dence. J Complement Integrat Med. 2021;18(3):553–9.
111. Hsu DT. Acupuncture: a review. Reg Anesth Pain Med. 1996;21(4):361–70.
112. Fu L etal. Eect of Acupuncture and Rehabilitation Therapy on the Recovery of Neurological Function and Prognosis of Stroke Patients.
Computational and Mathematical Methods in Medicine, 2022. 2022.
113. Lin J-G, Kotha P, Chen Y-H. Understandings of acupuncture application and mechanisms. Am J Trans Res. 2022;14(3):1469.
114. Chavez LM, etal. Mechanisms of acupuncture therapy in ischemic stroke rehabilitation: a literature review of basic studies. Int J Mol Sci.
2017;18(11):2270.
115. Kim YR, etal. Electroacupuncture promotes post-stroke functional recovery via enhancing endogenous neurogenesis in mouse focal
cerebral ischemia. PLoS ONE. 2014;9(2): e90000.
116. Hong J, etal. Electroacupuncture promotes neurological functional recovery via the retinoic acid signaling pathway in rats following
cerebral ischemia-reperfusion injury. Int J Mol Med. 2013;31(1):225–31.
117. Chen B, etal. Electro-acupuncture exerts benecial eects against cerebral ischemia and promotes the proliferation of neural progenitor
cells in the cortical peri-infarct area through the Wnt/β-catenin signaling pathway. Int J Mol Med. 2015;36(5):1215–22.
118. Lu T, etal. Electroacupuncture improves behavioral recovery and increases SCF/c-kit expression in a rat model of focal cerebral ischemia/
reperfusion. Neurol Sci. 2013;34:487–95.
119. Huang J, etal. Electroacupuncture promotes neural cell proliferation invivo through activation of the ERK1/2 signaling pathway. Int J
Mol Med. 2014;33(6):1547–53.
120. Xie G, etal. Electroacupuncture at Quchi and Zusanli treats cerebral ischemia-reperfusion injury through activation of ERK signaling.
Exp Ther Med. 2013;5(6):1593–7.
121. Tao J, etal. Electro-acupuncture at LI11 and ST36 acupoints exerts neuroprotective eects via reactive astrocyte proliferation after
ischemia and reperfusion injury in rats. Brain Res Bull. 2016;120:14–24.
122. Jingxi M, Yong L. Eects of electroacupuncture on expressions of angiogenesis factors and anti-angiogenesis factors in brain of experi-
mental cerebral ischemic rats after reperfusion. J Tradit Chin Med. 2008;28(3):217–22.
123. Kim JH, etal. Electroacupuncture acutely improves cerebral blood ow and attenuates moderate ischemic injury via an endothelial
mechanism in mice. PLoS ONE. 2013;8(2): e56736.
124. Zhang J-H, Wang D, Liu M. Overview of systematic reviews and meta-analyses of acupuncture for stroke. Neuroepidemiology.
2014;42(1):50–8.
125. Zhang, S.-h., etal., Eect of interactive dynamic scalp acupuncture on post-stroke cognitive function, depression, and anxiety: a multicenter,
randomized, controlled trial. Chinese journal of integrative medicine, 2022: p. 1–10.
126. Lin Y-J, etal. Chinese herbal medicine treatment improves the overall survival rate of individuals with hypertension among type 2 dia-
betes patients and modulates invitro smooth muscle cell contractility. PLoS ONE. 2015;10(12): e0145109.
127. Zhu T etal. (2021) Classical active ingredients and extracts of Chinese herbal medicines: pharmacokinetics, pharmacodynamics, and
molecular mechanisms for ischemic stroke. Oxidative medicine and cellular longevity, 2021.
128. Zhou L, Zuo Z, Chow MSS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol.
2005;45(12):1345–59.
Vol.:(0123456789)
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Review
129. Wen P-Y, etal. Tanshinone IIA increases levels of NeuN, protein disulfide isomerase, and Na+/K+-ATPase and decreases evidence of
microglial activation after cerebral ischemic injury. NeuroReport. 2016;27(6):435–44.
130. Kim YO, etal. Cytoprotective effect of Scutellaria baicalensis in CA1 hippocampal neurons of rats after global cerebral ischemia. J
Ethnopharmacol. 2001;77(2–3):183–8.
131. Cheng O, etal. Baicalin improved the spatial learning ability of global ischemia/reperfusion rats by reducing hippocampal apoptosis.
Brain Res. 2012;1470:111–8.
132. Liang W, Huang X, Chen W. The effects of baicalin and baicalein on cerebral ischemia: a review. Aging Dis. 2017;8(6):850.
133. Chen H, etal. Baicalin attenuates blood-brain barrier disruption and hemorrhagic transformation and improves neurological outcome
in ischemic stroke rats with delayed t-PA treatment: involvement of ONOO−-MMP-9 pathway. Transl Stroke Res. 2018;9:515–29.
134. Wang P, etal. Baicalin alleviates ischemia-induced memory impairment by inhibiting the phosphorylation of CaMKII in hippocampus.
Brain Res. 2016;1642:95–103.
135. Abdoulaye, I.A. and Y.J. Guo, A review of recent advances in neuroprotective potential of 3-N-butylphthalide and its derivatives. BioMed
research international, 2016. 2016.
136. Sun Y, etal. dl-3-n-butylphthalide promotes neuroplasticity and motor recovery in stroke rats. Behav Brain Res. 2017;329:67–74.
137. Liu R-Z, etal. Effects of Dl-3-n-butylphthalide on cerebral ischemia infarction in rat model by mass spectrometry imaging. Int J Mol
Sci. 2017;18(11):2451.
138. Cheng X, etal. Dl-3-n-butylphthalide promotes remyelination process in cerebral white matter in rats subjected to ischemic stroke.
Brain Res. 2019;1717:167–75.
139. Zhou PT, etal. Dl-3-N-butylphthalide promotes angiogenesis and upregulates sonic hedgehog expression after cerebral ischemia
in rats. CNS Neurosci Ther. 2019;25(6):748–58.
140. Chinese Pharmacopoeia C. Chinese pharmacopoeia. China Med Sci Press. 2015;1:191–3.
141. Qiu C-W, etal. Post-stroke gastrodin treatment ameliorates ischemic injury and increases neurogenesis and restores the Wnt/β-
Catenin signaling in focal cerebral ischemia in mice. Brain Res. 2019;1712:7–15.
142. Luo L, etal. Gastrodin exerts robust neuroprotection in the postischemic brain via its protective effect against Zn2+-toxicity and its
anti-oxidative effects in astrocytes. Animal Cells Syst. 2018;22(6):429–37.
143. Peng Z, etal. Gastrodin alleviates cerebral ischemic damage in mice by improving anti-oxidant and anti-inflammation activities and
inhibiting apoptosis pathway. Neurochem Res. 2015;40:661–73.
144. Wang S, etal. Gastrodin improves the neurological score in MCAO rats by inhibiting inflammation and apoptosis, promoting revas-
cularization. Int J Clin Exp Pathol. 2018;11(11):5343.
145. Xie W, etal. Panax notoginseng saponins: a review of its mechanisms of antidepressant or anxiolytic effects and network analysis
on phytochemistry and pharmacology. Molecules. 2018;23(4):940.
146. Chen J, etal. Ginsenoside Rg1 promotes cerebral angiogenesis via the PI3K/Akt/mTOR signaling pathway in ischemic mice. Eur J
Pharmacol. 2019;856: 172418.
147. Wang L, etal. Protective effect and mechanism of ginsenoside Rg1 in cerebral ischaemia-reperfusion injury in mice. Biomed Phar-
macother. 2018;99:876–82.
148. Li CT, Wang HB, Xu BJ. A comparative study on anticoagulant activities of three Chinese herbal medicines from the genus Panax and
anticoagulant activities of ginsenosides Rg1 and Rg2. Pharm Biol. 2013;51(8):1077–80.
149. Liu Y, etal. Panax notoginseng saponins attenuate atherogenesis accelerated by zymosan in rabbits. Biol Pharm Bull.
2010;33(8):1324–30.
150. Chu S-F, etal. Ginsenoside Rg1 protects against ischemic/reperfusion-induced neuronal injury through miR-144/Nrf2/ARE pathway.
Acta Pharmacol Sin. 2019;40(1):13–25.
151. Yang X etal. Natural Therapies for Cardiovascular Diseases. 2016, Hindawi.
152. Zhang G, etal. Neuroprotective eect and mechanism of action of tetramethylpyrazine nitrone for ischemic stroke therapy. NeuroMol
Med. 2018;20:97–111.
153. Zhang G, etal. Tetramethylpyrazine nitrone activates the BDNF/Akt/CREB pathway to promote post-ischaemic neuroregeneration and
recovery of neurological functions in rats. Br J Pharmacol. 2018;175(3):517–31.
154. Xu SH, etal. Tetramethylpyrazine-2’-O-sodium ferulate attenuates blood–brain barrier disruption and brain oedema after cerebral
ischemia/reperfusion. Hum Exp Toxicol. 2017;36(7):670–80.
155. Cabanas-Valdés R etal. (2021) The eectiveness of massage therapy for improving sequelae in post-stroke survivors. A systematic review
and meta-analysis. Int J Environ Res Publ Health 18(9): 4424.
156. Crane JD etal. (2012) Massage therapy attenuates inammatory signaling after exercise-induced muscle damage. Sci Trans Med 4(119):
119ra13–119ra13.
157. Gasibat Q, Suwehli W. Determining the benets of massage mechanisms: a review of literature. Rehabilitat Sci. 2017;3(2):58–67.
158. Yang X, Zhao H, Wang J. Chinese massage (Tuina) for the treatment of essential hypertension: a systematic review and meta-analysis.
Complement Ther Med. 2014;22(3):541–8.
159. Li S-S, etal. Therapeutic observation on tuina plus electroacupuncture for lateral humeral epicondylitis. J Acupuncture Tuina Sci.
2014;12:321–5.
160. Mok E, Woo CP. The eects of slow-stroke back massage on anxiety and shoulder pain in elderly stroke patients. Complement Ther Nurs
Midwifery. 2004;10(4):209–16.
161. Wang M, etal. Eect of Tui Na on upper limb spasticity after stroke: a randomized clinical trial. Ann Clin Trans Neurol. 2019;6(4):778–87.
162. Ali B, etal. Essential oils used in aromatherapy: A systemic review. Asian Pac J Trop Biomed. 2015;5(8):601–11.
163. Cooke B, Ernst E. Aromatherapy: a systematic review. Br J Gen Pract. 2000;50(455):493–6.
164. Shin B-C, Lee MS. Eects of aromatherapy acupressure on hemiplegic shoulder pain and motor power in stroke patients: a pilot study.
J Alternative Complementary Med. 2007;13(2):247–52.
165. Dohare P, etal. Neuroprotective ecacy and therapeutic window of curcuma oil: in rat embolic stroke model. BMC Complement Altern
Med. 2008;8:1–20.
Vol:.(1234567890)
Review
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
166. Vakili A, etal. Eect of lavender oil (Lavandula angustifolia) on cerebral edema and its possible mechanisms in an experimental model
of stroke. Brain Res. 2014;1548:56–62.
167. Wu S, etal. Curcumin ameliorates ischemic stroke injury in rats by protecting the integrity of the blood-brain barrier. Exp Ther Med.
2021;22(1):1–8.
168. Amantea D, etal. Prevention of glutamate accumulation and upregulation of phospho-akt may account for neuroprotection aorded
by bergamot essential oil against brain injury induced by focal cerebral ischemia in rat. Int Rev Neurobiol. 2009;85:389–405.
169. Contrada M, etal. Aromatherapy in Stroke Patients: Is it Time to Begin? Front Behav Neurosci. 2021;15: 749353.
170. Lee JH, etal. The effects of aroma massage and foot bath on psychophysiological response in stroke patients. J Phys Ther Sci.
2017;29(8):1292–6.
171. Maltese PE, etal. Molecular foundations of chiropractic therapy. Acta Bio Medica. 2019;90(Suppl 10):93.
172. Gleberzon BJ, Cooperstein R, Perle SM. Can chiropractic survive its chimerical nature? J Can Chiropr Assoc. 2005;49(2):69.
173. Holt K, etal. The eects of a single session of chiropractic care on strength, cortical drive, and spinal excitability in stroke patients. Sci
Rep. 2019;9(1):2673.
174. Navid MS, etal. Investigating the eects of chiropractic spinal manipulation on EEG in stroke patients. Brain Sci. 2020;10(5):253.
175. Holt K, etal. The eects of 4 weeks of chiropractic spinal adjustments on motor function in people with stroke: a randomized controlled
trial. Brain Sci. 2021;11(6):676.
176. Deng H, Shen X (2013) The mechanism of moxibustion: ancient theory and modern research. Evid-Based Complementary Alternative
Med 2013.
177. Lee MS, etal. Moxibustion for stroke rehabilitation: systematic review. Stroke. 2010;41(4):817–20.
178. Chen G etal. Ecacy and safety of grain moxibustion in hemiplegia: a systematic review and meta-analysis protocol. Medicine, 2019.
98(17).
179. Yang L, etal. Warm-needle moxibustion for spasticity after stroke: a systematic review of randomized controlled trials. Int J Nurs Stud.
2018;82:129–38.
180. Meng X etal. (2023) Ecacy and safety of a novel plum blossom needling with mild moxibustion device for upper limb pain disorder
and motor dysfunction in patients with stage 1 post-stroke shoulder-hand syndrome: study protocol for a multi-center, single-blind,
randomized sham-controlled trial. J Pain Res p 407–420.
181. Liu F, etal. Eects of moxibustion on cognition and activities of daily living in post-stroke cognitive impairment: a systematic review and
meta-analysis of randomized controlled trials. J Nurs Scholarsh. 2023;55(2):464–76.
182. Guo S-Q, etal. Moxibustion for treating patients with post-stroke depression: a systematic review and meta-analysis. Ann Palliat Med.
2022;11:85–97.
183. Parasuraman S, Thing GS, Dhanaraj SA. Polyherbal formulation: concept of ayurveda. Pharmacogn Rev. 2014;8(16):73–80.
184. Paudyal B, etal. Adverse events with ayurvedic medicines- possible adulteration and some inherent toxicities. Wellcome Open Res.
2019;4:23.
185. Telles S, etal. Benets and adverse eects associated with yoga practice: a cross-sectional survey from India. Complement Ther Med.
2021;57: 102644.
186. Azhar M. Adverse eect of unani pharmacopeial formulation Habb-E-Shifa. J Pharmacovigil. 2018;6(269):2.
187. Posadzki P, Alotaibi A, Ernst E. Adverse eects of homeopathy: a systematic review of published case reports and case series. Int J Clin
Pract. 2012;66(12):1178–88.
188. Stub T etal. (2022) Adverse eects in homeopathy. A systematic review and meta-analysis of observational studies. Explore 18(1):
114–128.
189. Hui J etal. Eects of Tai Chi on health status in adults with chronic heart failure: A systematic review and meta-analysis. Front Cardiovasc
Med 2022. 9.
190. Park M, etal. Eects of Tai Chi and Qigong on the mobility of stroke survivors: a systematic review and meta-analysis of randomized
trials. PLoS ONE. 2022;17(11): e0277541.
191. Chan MWC, etal. Safety of acupuncture: overview of systematic reviews. Sci Rep. 2017;7(1):3369.
192. Zhao XF, etal. Acupuncture for stroke: evidence of eectiveness, safety, and cost from systematic reviews. Top Stroke Rehabil.
2012;19(3):226–33.
193. Kam PCA, Liew S. Traditional Chinese herbal medicine and anaesthesia. Anaesthesia. 2002;57(11):1083–9.
194. Lai J-N, Tang J-L, Wang J-D. Observational studies on evaluating the safety and adverse eects of traditional chinese medicine. Evid-Based
Complementary Alternat Med. 2013;2013(1): 697893.
195. Yin P, etal. Adverse events of massage therapy in pain-related conditions: a systematic review. Evid-Based Complementary Alternat Med.
2014;2014(1): 480956.
196. Posadzki P, Alotaibi A, Ernst E. Adverse eects of aromatherapy: A Systematic review of case reports and case series. Int J Risk Saf Med.
2012;24:147–61.
197. Rothwell DM, Bondy SJ, Williams JI. Chiropractic manipulation and stroke. Stroke. 2001;32(5):1054–60.
198. Hackenberger PN, Janis JE A Comprehensive Review of Medicinal Leeches in Plastic and Reconstructive Surgery. Plastic and Reconstruc-
tive Surgery—Global Open, 2019. 7(12): e2555.
199. Lee MS, etal. Cupping for stroke rehabilitation: a systematic review. J Neurol Sci. 2010;294(1):70–3.
200. Al-Bedah AMN, etal. The medical perspective of cupping therapy: eects and mechanisms of action. J Tradit Complement Med.
2019;9(2):90–7.
201. Shah SH, Engelhardt R, Ovbiagele B. Patterns of complementary and alternative medicine use among United States stroke survivors. J
Neurol Sci. 2008;271(1):180–5.
202. Grau-Sánchez J, etal. Enriched Music-supported Therapy for chronic stroke patients: a study protocol of a randomised controlled trial.
BMC Neurol. 2021;21(1):1–16.
203. Tong Y, etal. Music-supported therapy (MST) in improving post-stroke patients’ upper-limb motor function: a randomised controlled
pilot study. Neurol Res. 2015;37(5):434–40.
Vol.:(0123456789)
Discover Medicine (2025) 2:80 | https://doi.org/10.1007/s44337-025-00279-9
Review
204. Huang W-H etal. The eectiveness of music therapy on hand function in patients with stroke: A systematic review of randomized con-
trolled trials. Front Neurol 2021: 624.
205. Pospelova M etal. Hirudotherapy in the treatment of cerebrovascular disease: Past and present. " Arterial’naya Gipertenziya"(" Arterial
Hypertension"), 2018. 24(2): 217–222.
206. Singh AP. Medicinal leech therapy (hirudotherapy): a brief overview. Complement Ther Clin Pract. 2010;16(4):213–5.
207. Haq AU etal. Hirudotherapy in Veterinary Practice: A Modern Twist to Ancient Science.
208. Wei-Hui L, etal. Identication and characterization of a novel neuropeptide (neuropeptide Y-HS) from leech salivary gland of Haemadipsa
sylvestris. Chin J Nat Med. 2016;14(9):677–82.
209. De-Miguel F. Steps in the formation of neurites and synapses studied in cultured leech neurons. Braz J Med Biol Res. 2000;33:487–97.
210. Heinz P, etal. Hirudotherapy in reconstructive surgery: case-reports and review. Acta Chir Plast. 2020;62(3–4):95–102.
211. Liu J, etal. Eect of hirudin on arterialized venous ap survival in rabbits. Biomed Pharmacother. 2021;142: 111981.
212. Yantis MA, O’Toole KN, Ring P Leech therapy. Am J Nurs, 2009. 109(436–42; quiz 43.
213. Munshi Y, etal. Leeching in the history–a review. Pak J Biol Sci. 2008;11(13):1650–3.
214. Qureshi NA, etal. History of cupping (Hijama): a narrative review of literature. J Integrative Med. 2017;15(3):172–81.
215. Aboushanab TS, AlSanad S. Cupping therapy: an overview from a modern medicine perspective. J Acupunct Meridian Stud.
2018;11(3):83–7.
216. Al-Bedah AM, etal. The use of medical simulation in cupping therapy training: a novel idea from the national center for complementary
and alternative medicine. J Complement Altern Med Res. 2016;1(3):1–4.
217. Michalsen A, etal. Eects of traditional cupping therapy in patients with carpal tunnel syndrome: a randomized controlled trial. J Pain.
2009;10(6):601–8.
218. Yoo SS, Tausk F. Cupping: east meets west. Int J Dermatol. 2004;43(9):664–5.
219. Kim J-I, etal. (2011) Cupping for treating pain: a systematic review. Evid-Based Complement Alternative Med 2011..
220. Ghods R, Sayfouri N, Ayati MH. Anatomical features of the interscapular area where wet cupping therapy is done and its possible relation
to acupuncture meridians. J Acupunct Meridian Stud. 2016;9(6):290–6.
221. Kim M, etal. The eectiveness and safety of cupping therapy for stroke survivors: A systematic review and meta-analysis of randomized
controlled trials. J Korean Med. 2021;42(4):75–101.
222. Park Y. Cupping plus blood letting therapy of hemiplegia after stroke of shoulder pain in 30 cases. Traditional Chin Med Res.
2008;21(4):54–6.
223. Huang Z etal. (2018) Eects of pricking and cupping combined with rehabilitation training on elbow exion spasticity of upper limb
after stroke and its IEMG value. Zhongguo Zhen jiu= Chinese Acupuncture & Moxibustion, 38(2): 119–125.
224. Lee MS, etal. Cupping for stroke rehabilitation: a systematic review. J Neurol Sci. 2010;294(1–2):70–3.
225. Vitale A. An integrative review of Reiki touch therapy research. Holist Nurs Pract. 2007;21(4):167–79.
226. VanderVaart S etal. A systematic review of the therapeutic eects of Reiki. The J Alternative Complementary Med 2009. 15(11): 1157–1169.
227. Bullock M, Reiki: a complementary therapy for life. Am J Hospice Palliative Medicine®, 1997. 14(1): 31–33.
228. Billot M, etal. Reiki therapy for pain, anxiety and quality of life. BMJ Support Palliat Care. 2019;9(4):434–8.
229. Shiett SC, etal. Eect of Reiki treatments on functional recovery in patients in poststroke rehabilitation: a pilot study. J Alternative
Complementary Med. 2002;8(6):755–63.
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional aliations.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Background Post-stroke shoulder-hand syndrome (PS-SHS), a common neurological comorbidity after stroke episodes, poses a grave threat on patients’ functional recovery. Preliminary trials have demonstrated that the acupuncture and moxibustion treatment, including a dermal acupuncture tapping method known as plum blossom needling (PBN) can improve pain and motor dysfunctions in patients with PS-SHS. However, there are few reports describing simultaneous moxibustion treatment in combination with PBN. Hence, a novel plum blossom needle device with mild moxibustion (PBNMM) was developed to evaluate its potential efficacy and safety in patients with stage 1 PS-SHS. Materials and Methods This multicenter, sham-controlled, randomized controlled trial (RCT) will recruit 102 eligible patients with stage 1 PS-SHS from three clinical centers, randomly allocated in a ratio of 1:1:1 to the PBNMM group, PBNMM with no moxa smoke (PBNMM-NMS) group and sham control group. Patients in each group will receive a 30-minute treatment once per day for 4 weeks, with 5 consecutive sessions per week, for a total of 20 sessions. The primary outcome measure will be defined as the decreased scores from baseline in the visual analog scale (VAS) assessment at week 4. Secondary outcome measures will include scores on the Fugl-Meyer Assessment of the Upper Extremity Scale (FMA-UE), the Modified Barthel Index (MBI), and the somatosensory evoked potential (SEP) records. All outcomes will be evaluated at baseline and weeks 4, 5, 6 and 10, and the intention-to-treat analysis will be applied. Conclusion This study aims to provide robust evidence for the efficacy and safety of the PBNMM for PS-SHS treatment, as well as the specific impact of moxibustion smoke itself in dealing with PS-SHS. Clinical Trial Registration Chinese Clinical Trial Registry No. ChiCTR2200062441. Registered on 7 August 2022.
Article
Full-text available
Background Stroke survivors often experience impaired mobility and physical functions. Tai Chi and Qigong have been shown to have physical and psychological benefits for stroke patients. Purpose To summarize the evidence on Tai Chi and Qigong for improving mobility in stroke survivors, specifically the ability to walk, dynamic balance, and activities of daily living (ADL). Methods Independent searches of 16 electronic databases in English, Korean, and Chinese from their inception until December 2021 were conducted by two research teams. Methodological quality was assessed using Cochrane’s risk of bias tool 2.0. Comprehensive Meta-Analysis 3.0 software was used to calculate effect sizes with subgroup analysis and to assess heterogeneity and publication bias. Results The meta-analysis included 27 randomized trials (18 with Tai Chi and 9 with Qigong) on stroke survivors (N = 1,919). None of the studies were considered at high risk of bias, about 70% had some concerns, and 30% were considered low risk. Meta-analysis of 27 randomized controlled trials with random-effects models indicated that Tai Chi and Qigong effectively improved mobility, specifically on the ability to walk (Hedges’g = 0.81), dynamic balance (Hedges’g = 1.04), and ADL (Hedges’g = 0.43). The effects of Tai Chi and Qigong were significant for short-term and long-term programs (Hedges’g 0.91 vs. 0.75), and when compared with active controls and no treatment group (Hedges’g 0.81 vs. 0.73). Conclusion Tai Chi and Qigong performed for 12 weeks or less were effective in improving the mobility of stroke survivors. Further studies are warranted to assess whether Tai Chi and Qigong work best as an adjunct to rehabilitation, an effective alternative to rehabilitation or as a maintenance strategy, and whether the results could be further optimized by assessing different schools of Tai Chi and Qigong, different types of stroke patients, and different points in the post-stroke recovery process. PROSPERO registration number This study has been registered on the UK National Institute for Health Research (http://www.crd.york.ac.uk/PROSPERO) PROSPERO registration number: CRD42020220277.
Article
Full-text available
Background Chronic heart failure (CHF) is among the top causes of cardiovascular morbidity, and most patients with CHF have poor health status. Tai Chi, a mind-body exercise that originated in China, is beneficial for health status. This study was conducted to evaluate the effects of Tai Chi on health status in adults with CHF. Methods The Cochrane Library, PubMed, Embase, Web of Science, China National Knowledge Infrastructure, Wanfang Database, Chinese Biomedical Database, and Chinese Scientific Journal Database were searched from the inception to 22 October 2021. This meta-analysis was performed using the fixed- or random-effects model. Continuous outcomes were carried out using mean difference (MD) or standardized mean difference (SMD) with 95% confidence interval (CI). Dichotomous outcomes were determined using risk ratio (RR) with 95%CI. The Grading of Recommendations, Assessment, Development and Evaluations (GRADE)pro Guideline Development Tool (GDT) online software was used to present outcome-specific information regarding overall certainty of evidence from studies. Results In total, 15 studies including 1,236 participants were finally included. Compared with usual care alone, Tai Chi combined with usual care achieved efficacy in improving Minnesota Living with Heart Failure Questionnaire (MD = −8.51; 95% CI: −10.32 to −6.70; p < 0.00001), 6-min walk test (MD = 43.47; 95% CI: 33.38 to 54.10; p < 0.00001), left ventricular ejection fraction (MD = 6.07; 95% CI: 3.44 to 8.70; p < 0.00001), B-type natriuretic peptide/N-terminal fragment of pro-BNP (SMD = −1.12; 95% CI: −1.70 to −0.54; p = 0.0002), Hamilton Depression Rating Scale (MD = −2.89; 95% CI: −4.87 to −0.91; p = 0.004), Pittsburgh Sleep Quality Index (MD = −2.25; 95% CI: −3.88 to −0.61; p = 0.007), timed up and go test (MD = −1.34; 95% CI: −2.50 to −0.19; p = 0.02), and reduced the risk of heart failure hospitalization (RR = 0.47; 95% CI: 0.25 to 0.88; p = 0.02). However, there was no difference in the outcome of peak oxygen uptake (MD = 1.38; 95% CI: −1.51 to 4.28; p = 0.35). All-cause mortality or cardiovascular death could not be evaluated due to insufficient data. The certainty of evidence ranged from very low to moderate due to the risk of bias, inconsistency, imprecision, and publication bias. Conclusion Tai Chi might be safe and showed beneficial effects on health status in patients with CHF. However, more high-quality and long-term studies are still needed to further evaluate the effects of Tai Chi.
Article
Full-text available
Human body behaves like a rechargeable battery which utilizes the energy on the earth and the entire universe for recharging itself. The mother earth and the entire universe help and provide us everything needed for the spiritual, mental and bodily healing. Besides human beings have a constant flow of energy from the feet to the minds. The Energy Healing Techniques believe that this flow of energy can heal the body by itself in a natural way. The paradigm shift from the traditional medicine system which reveals us about the meridian system and the energy chakra vortexes to the modern science all tell us about energy system and be indebted to the basic principle that every substance is produced of energy. Modern era medical practitioners have recognized the benefits of energy healing and have started implementing it as one of the supplements to the modern medical treatment. This review provides light into the classification of energy healing techniques, global and national impact of Energy Healing Techniques, the various conventional and modern approaches for the measurement of biofield energy and how Information Technology is involved in the various techniques. Energy healing techniques and the use of computers and other information technology in the therapeutic modalities were identified and analyzed using databases from different sources. Information was extracted from the topic related books and journals in addition to the relevant websites. This review summarizes various conventional and modern approaches for measurement of biofield energy and the use of computers and information technology for the same. The structural analysis infers that extended usage of computerized imaging and software analysis is the need of the hour for scientific evidences of the effectiveness of these therapies.
Article
Objectives: ncluding stroke. The aim of this study was to systematically review the clinical evidence of CT for stroke.Methods: To identify randomized controlled trials (RCTs) reporting the effectiveness and/or safety of CT, seven databases including PubMed, EMBASE, and Cochrane Library were searched for articles published from January 2000 to February 2021 without language restrictions. Meta-analysis was performed using Review Manager 5.4 software and the results were presented as mean difference (MD) or standard mean difference (SMD) for continuous variables and odds ratio (OR) for diverse variables with 95% confidence intervals (CIs). Assessment of the methodological quality of the eligible trials was conducted using the Cochrane Collaboration tool for risk of bias in RCTs.Results: Twenty-two RCTs with 1653 participants were included in the final analysis. CT provided additional benefit in improving upper limb motor function (Fugl-Meyer assessment for upper limb motor function, MD 6.91, 95% CI 4.64 to 1.67, P<0.00001) and spasticity (response rate, OR 3.28, 95% CI 1.31 to 8.22, P=0.08) in stroke survivors receiving conventional medical treatment. These findings were supported with a moderate level of evidence. CT did not significantly increase the occurrence of adverse events.Conclusions: This study demonstrated the potential of CT to be beneficial in managing a variety of complications in stroke survivors. However, to compensate for the shortcomings of the existing evidence, rigorously designed large-scale RCTs are warranted in the future.
Article
Acupuncture involves the stimulation of acupoints, which are located at specific sites of the human body, by insertion of fine metal needles, followed by manipulation. Acupuncture has been proven to be an effective treatment in pain relief. Available evidence showed that acupuncture alleviates acute pain in conditions such as postoperative pain, acute back pain, labour pain, primary dysmenorrhea, tension-type headaches and migraines. In addition, acupuncture relieves chronic pain, for example, low back pain (LBP), knee osteoarthritis (KOA), headache, shoulder pain, and neck pain. For other diseases like insomnia, drug addiction and stroke, more high-quality randomized control trials (RCTs) are needed to confirm the efficacy of acupuncture, although there are particular difficulties surrounding adequate blinding and control group designs. Recent biomedical technology unveils the mechanisms of acupuncture. Studies have found that adenosine triphosphate (ATP) and transient receptor potential vanilloid (TRPV) channels are involved in the stimulation of acupuncture at the acupoint area. In the central nervous system (CNS), neurotransmissions including opioids, serotonin, norepinephrine, orexin and endocannabinoid are modulated by acupuncture to induce analgesia. Moreover, acupuncture reduces cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) levels on the peripheral level by acting on the hypothalamic-pituitary-adrenal (HPA) axis, mediating peripheral opioid release. Acupuncture helps to treat insomnia by inhibiting sympathetic activity and down-regulating the HPA axis. Additionally, acupuncture reduces the effects of positive and negative reinforcements by modulating dopamine release in the nucleus accumbens. Recently, i-needles have been developed to allow for the analysis of metagenomics, meta-transcriptomics, and host-microbiome relationships following acupuncture, while skin implantable microsensors or needle-shaped microsensors are feasible for monitoring real-time microenvironmental changes in acupoints and even target organs. These studies may further accelerate the understanding of acupuncture's action mechanism.
Conference Paper
Ischemic stroke is one of the two main forms of cerebrovascular accident that ranks the second highest leading killer worldwide. An attack of ischemic stroke would lead to rapid death of neurons accompanied with inflammatory events in the brain, causing acquired disabilities for the survivors. Yet better drugs for ischemic stroke treatment are still in great need. In this literature review, three major compounds are mentioned and concluded that 6-shogaol, 6-paradol, and zingerone have neuroprotective potential and discussed the possibility to make them promising drugs for ischemic stroke treatment.
Article
Background: Post-stroke cognitive impairment (PSCI) imposes a huge burden on patients and society as a whole; however, unequivocally effective treatments for PSCI are still lacking. Therefore, the exploration of effective and safe non-pharmacological treatment modalities for PSCI is a key imperative. Moxibustion has been widely used for cognitive rehabilitation; however, there is a paucity of systematic reviews of the available evidence. Therefore, we conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) that investigated the effectiveness of moxibustion for treatment of PSCI to provide evidence base for the treatment of PSCI with moxibustion. Objective: To evaluate the efficacy of moxibustion in improving cognitive function and activities of daily living (ADLs) in patients with PSCI. Design: Systematic review and meta-analysis of RCTs. Participants: Patients with a clinical diagnosis of PSCI. Review methods: Relevant studies published in English or Chinese were retrieved from ten databases until December 2021. RCTs that assessed the efficacy of moxibustion on cognitive functioning and ADL in patients with PSCI were included. Two reviewers independently identified the trials and extracted the data. Risk-of-bias was assessed using the Cochrane Risk of Bias Tool. Cochrane's Review Manager (RevMan 5.4) software was used for the meta-analysis. Results: Eighteen RCTs (1290 participants) qualified the inclusion criteria and were included. Compared with the control group, the addition of moxibustion significantly improved the cognitive function, evaluated using the Montreal Cognitive Assessment (MoCA) [pooled mean difference (MD): 2.27, 95% CI: 1.98, 2.55, I2 = 22%]. The pooled MD of Mini-Mental State Examination (MMSE) score was 1.85 (95% CI: 1.56, 2.15, I2 = 26%), and the pooled odds ratios (OR) total effective rate was 4.74 (95% CI: 2.55, 8.80, I2 = 0%) (p < 0.05 for all). Moxibustion also significantly improved ADL, assessed using Modified Barthel Index (MBI) (pooled MD = 4.10, 95% CI: 2.10 to 6.10, I2 = 0%) and Barthel Index (pooled MD: 8.63, 95% CI: 7.47, 9.79, I2 = 5%) (p < 0.05 for all). Conclusions: Compared with control group, the addition of moxibustion significantly improved the cognition and ADL of patients with PSCI. Clinical relevance: Nurses can incorporate moxibustion into the rehabilitation nursing of PSCI.
Article
Introduction: Stroke is one of the leading causes of death and disability in India. Stroke survivors may suffer from lifelong physical and cognitive frailty. There is a need for more studies on the prevalence and determinants of this debilitating disease at the national level. Thus, assessing the factors associated with stroke is vital to developing appropriate preventive strategies in India. Methods: Data from the Longitudinal Aging Study in India wave 1 (2017-2018) are utilized for this analysis. The survey collected demographics, social, economic, and health data, including lifestyle factors and stroke, from 65,900 older adults ≥45 years representing all states and union territories. Stroke prevalence was calculated for each independent variable, and the differences were compared using the χ2 test. An unconditional multivariable logistic regression model was used to obtain the adjusted odds ratios (AOR) and 95% confidence intervals (CIs) of each lifestyle and socioeconomic variable for stroke prevalence. Results: The prevalence of self-reported stroke was 1.71% (95% CI: 1.61-1.80). Older adults with hypertension (AOR=3.69, 95% CI: 2.95-4.62), family history of stroke (AOR=3.09; 95% CI: 2.33-4.12), arrhythmias (AOR=2.27; 95% CI: 1.20-4.29), physical inactivity (AOR=1.91; 95% CI: 1.55-2.34) were strong contributors of stroke. Diabetes and high cholesterol individuals have 1.5 times more odds for stroke than those without those conditions. Increasing age (AOR=1.57 for 55-69 older adults, and AOR 2.05 for ≥70 years), male sex (AOR=1.75; 95% CI 1.36-2.26), and rich (AOR=1.58; 95% CI: 1.21-2.06) were also associated with increased odds for stroke. Conclusion: The prevalence of stroke was high among adults aged ≥45 years in India. Hypertension, family history of stroke, arrhythmias, and low physical activity were significant contributors to stroke. The findings suggest that preventing and controlling these lifestyle conditions and behaviors may help prevent stroke.